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CHAPTER I 
INTRODUCTION 
Bacteremia is an ongoing phenomenon that is usually handled by a 
healthy person without any difficulty or external manifestation of the 
problem. Occasionally the bacterial insult becomes overwhelming and 
induces a sequence of changes, the so-called septic state. Depending on 
the ability of host to respond appropriately to the insult, the changes 
may be mild and reversible or severe and irreversible - culminating in 
death in septic shock. In the clinical setting, sepsis often progesses 
significantly before it is recognized. In many cases even aggressive 
treatment with antibiotics, cardiopulmonary support, or steroids fail to 
curtail progression into a shock state and death ensues (92,97). In this 
regard, approximately 1% of hospital patient admissions annually results 
in gram-negative sepsis; thirty to fifty percent of these cases will be 
fatal. McCabe et al (91) projected that at these rates as many as 
300,000 episodes of sepsis and more than 100,000 fatalities from 
gram-negative infections occur in the U.S. each year. Therefore 
gram-negative sepsis and the consequences of sepsis are significant 
health problems. 
Studies performed to characterize the basic pathophysiologic 
processes of sepsis have been conducted for nearly 100 years and yet 
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mechanisms responsible have not been satisfactorally elucidated. Some of 
the lack of insight centers around the experimental model of sepsis. At 
this time there is no universally accepted model of sepsis, although 
some recent models may duplicate the symptoms of clinical sepsis better 
than earlier models (136). One particularly reproducible model of sepsis 
is the endotoxin injection model. Endotoxin is a 
lipoprotein-carbohydrate complex found in the cell wall of gram-negative 
bacteria. The bacterial lipopolysaccharide consists of a highly variable 
outer region composed of repeating oligosaccharide units and a 
relatively constant core region containing a small number of amino 
sugars and the biologically active lipid A moiety. Endotoxin can be 
extracted from the cell wall by a number of methods; most commonly 
including treatment with trichloroacetic acid (Boivin method) or 
phenol-water (Westphal method). 
Endotoxin has been found to cause a shock syndrome and 
eventually death in a variety of experimental animals. It has also been 
implicated as the precipitating factor in experimental animal sepsis 
(139). Approximately thirty years ago it was suggested that human 
gram-negative shock was also caused by endotoxins. Spink et al (120) 
postulated that that the antibacterial action of antibiotics destroys 
viable organisms, liberating antigenic material, presumably endotoxin. 
This theory was supported by clinical studies of Borden and Hall (12) 
and Braude et al (14) who observed severe shock in patients infected 
with gram-negative organisms. The relationship of endotoxin to sepsis 
has not been unanimously accepted, and many investigators maintain that 
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the cardiovascular and metabolic responses to endotoxin in experimental 
animals do not necessarily correlate with the clinical picture of 
sepsis. These discrepancies may be related to species variability or 
time course of the response. Recently, however, evidence has accumulated 
that strongly suggests the pathophysiologic role of endotoxin in human 
gram-negative bacteremia. Ziegler et al (142) have significantly 
improved survival of patients exhibiting gram-negative bacteremia, by 
treating them with human antiserum produced against the core of 
endotoxin. Similarly, freeze-dried human plasma rich in anti-LPS 
immunoglobulin G was used to treat septic shock in obstetric and 
gynecological patients (71). Treated patients had a significantly 
improved survival rate and the survivors had a shorter hospital stay 
than survivors of conventional methods. In close agreement with these 
studies, Pollack et al (112) have observed enhanced survival in 
Pseudomonas aeruginosa septicemia in patients who exhibited increased 
plasma concentrations of endogenous core-specific antibodies. The data 
from these studies supports the use of the endotoxin model as relevant 
to the study of the pathophysiology of sepsis. 
The condition of endotoxicosis is associated with a plethora of 
metabolic, humoral and hemodynamic alterations (58). Of particular 
consequence is the depression in myocardial performance that develops 
during endotoxicosis. Historically, a decrease in venous return, due to 
peripheral 
the pumping 
pooling, has been considered to contribute to the failure of 
action of the heart, especially in the early stages of 
endotoxicosis. More recently, evidence has emerged that suggests that 
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myocardial dysfunction also occurs as a result of an intrinsic defect. 
The mechanisms of this dysfunction are currently under investigation in 
numerous laboratories. 
Activation of the sympathetic nervous system is an important 
compensatory mechanism that proceeds during endotoxicosis. Early in the 
septic insult sympathetic activity supports the metabolic and 
cardiovascular adjustments to endotoxicosis. Eventually the sustained 
sympathetic hyperactivation becomes detrimental to the animal and 
contributes to the pathogenesis of the endotoxicosis (78). There is some 
evidence that high levels of catecholamines directly cause lesions in 
the heart (102) and catecholamines are also implicated as causing 
myocardial adrenergic receptor dysfunction in similar stress states 
(131,138). In addition, it is believed that the myocardium becomes 
refractory to catecholamine stimulation during endotoxicosis 
(1,6,107,114). Apparently the beta-adrenergic effector system in the 
heart is modified in endotoxicosis, the precise mechanisms of such 
changes have not been elucidated. 
Recent technicological advances have contributed substantially 
to the understanding of adrenergic receptor structure and function in 
normal and pathophysiological situations (45). With the apparent 
alteration in beta-adrenergic receptor mediated mechanisms developing 
during endotoxicosis, these techniques are directly applicable to the 
analysis of myocardial beta-adrenergic receptor characteristics in this 
pathophysiological condition. 
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Therefore, this dissertation: 1) reviews the evidence for 
myocardial dysfunction in endotoxin shock and the related mechanisms for 
the dysfunction, 2) reviews the role of the sympathetic nervous system 
in supporting the cardiovascular system in shock and how this support 
may be modified, 3) develops an approach to studying adrenergic 
post-synaptic mechanisms in the heart during endotoxicosis, 4) presents 
experimental findings pertinent to the questions raised, and 5) relates 
the present results to the existing literature. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
A. Evidence for Myocardial Dysfunction in Endotoxicosis 
The role of the heart in the pathogenesis of endotoxin shock is 
still somewhat controversial, however it is generally accepted that 
there is a decline in myocardial performance as endotoxicosis proceeds 
(76). Myocardial performance can be defined as the ability of the heart 
to pump blood to the periphery as determined by preload, afterload, 
heart rate, and contractility. Therefore myocardial performance is 
influenced by extracardiac as well as intracardiac factors. There is 
still considerable debate whether the decrease in myocardial 
performance during endotoxicosis is a result of intrinsic myocardial 
dysfunction or if it is due to alterations in the peripheral 
vasculature. In all probability both myocardial failure and vascular 
collapse contribute to the decline, with the time course of the 
endotoxicosis dictating which is the predominant factor. 
Initially, it was believed that the decline in myocardial 
performance during endotoxicosis was related solely to a decrease in 
venous return (34). Hinshaw et al (50) noted vascular changes, 
particularly increased venous resistance, during irreversible endotoxic 
6 
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shock. They suggested that the vascular changes could account for the 
hypotension and pooling that occurs during endotoxin shock. It is likely 
that these changes contribute to a decreased venous return leading to a 
decline in myocardial performance 
Experiments by Lillehei et al (77) supported the role of the 
vasculature in myocardial performance alterations. They observed 
decreased cardiac output and visceral organ blood flow in dogs during 
the latter stages of endotoxicosis even while blood pressure was 
supported 
attributed 
at normal levels by increased peripheral resistance. This was 
to the destructive effect of catecholamines on the 
microcirculation. Treatment with plasma or low molecular weight dextran 
concomitantly with phenoxybenzamine, an alpha-adrenergic receptor 
antagonist, brought peripheral resistance and plasma catecholamine 
levels back towards normal and increased venous return, cardiac output 
and organ blood flow. They believed that any decrease in myocardial 
function during endotoxicosis was a result of peripheral vascular 
defects. 
Early evidence for myocardial dysfunction in endotoxicosis was 
reported by Solis and Downing (118). Left ventricular function was 
studied in an autosupported feline heart preparation. They observed that 
within 15-30 min of endotoxin administration, both stroke volume and 
ejection rate for a given left ventricular end diastolic pressure at 
constant heart rate and aortic pressure were reduced, as compared to 
control. The 
the infusion 
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reduction in ventricular contractility was attenuated by 
of inotropic agents as late as one hour after 
administration of endotoxin. They suggested that the decrease in 
ventricular contractility may contribute to the circulatory failure in 
endotoxin shock but did not offer any mechanism of the deterioration. 
Goodyer, in 1967 (40), using anesthetized dogs, correlated 
ventricular function changes with measurements of systemic oxygen debt 
and metabolic indices of myocardial anoxia. Myocardial failure was not 
indicated until late in endotoxin shock and only at a time when the dogs 
were in severe oxygen debt. When dogs received beta-adrenergic receptor 
blockade along with endotoxin administration ventricular function was 
impaired. Thus the myocardium may be undergoing a slow but progressive 
deterioration that is masked by increased sympathetic drive. Goodyer 
concluded that myocardial damage manifests when sympathetic drive fails 
or is no longer effective. The cause of the myocardial impairment could 
not be related to anoxia or acidosis in this study and therefore 
remained in question. 
In contrast to these findings, Hinshaw et al (51) found no 
deleterious effect of propranolol on canine isolated heart preparations 
after endotoxin administration. Cardiac performance was unimpaired after 
endotoxin even in the presence of beta-adrenergic blockade. The dose of 
endotoxin used in this study was approximately one-fourth of that used 
by Goodyer (40), a discrepancy that serves to demonstrate the difficulty 
in comparing data between studies. In a subsequent study with the same 
9 
preparation as above, in which they controlled aortic pressure and 
cardiac output, Hinshaw et al (52) found no direct toxic effect of 
endotoxin on the canine myocardium within 3.5 hours. However they 
suggested that prolonged systemic hypotension may precipitate cardiac 
failure due to decreased coronary perfusion pressure and flow. It is 
important to note that at this time the Hinshaw group used a relatively 
short experimental period to assess cardiovascular parameters during 
endotoxicosis. 
Berk et al (5) also administered propranolol to endotoxic dogs 
and observed an increased survival rate in the propranolol-treated dogs 
as compared to those that received only endotoxin. They concluded, 
similarly to Lillehei et al (77), that the beneficial effects of 
adrenergic antagonists were at the level of the microvasculature and not 
at the heart, in that arteriovenous shunts in the lung and splanchnic 
area remained closed and pooling of blood was avoided. Myocardial 
function was not directly assessed in by Berk et al (5). 
Cann et al (16) studied the cardiovascular response of nonseptic 
and septic dogs to various perturbations. Using volume loading of dogs 
with dextran to increase preload, no clearcut evidence was found for any 
change in cardiovascular performance in sepsis. However, when the dogs 
received an infusion of isoproterenol just prior to the dextran, the 
cardiac index of the septic dog did not increase as seen in the control 
state. In fact the cardiac index-mean right atrial pressure curve of the 
septic dog with the beta-adrenergic agonist was not significantly 
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different from septic dogs with only volume expansion. When control and 
septic dogs underwent beta-adrenergic blockade before dextran expansion 
the control dogs were able to raise their cardiac index to levels 
comparable to dextran treatment alone despite no significant change in 
heart rate. In contrast the septic dogs, which also had no heart rate 
increases could not increase cardiac index even at high filling 
pressures. These data suggest that myocardial function, especially those 
mechanisms relating to increasing stroke volume, are depressed during 
sepsis. These data also suggest that the septic heart is dependent on 
adrenergically mediated increases in heart rate to increase cardiac 
output. 
In contrast to their earlier studies Hinshaw et al (53) noted 
irreversible myocardial failure in isolated dog hearts six to nine hours 
after endotoxin injection. They observed a markedly elevated left 
ventricular end diastolic pressure, decreased maximum change in left 
ventricular pressure and the need of inotropic agents to support the 
endotoxic heart. At this time they could only conjecture as to the 
precipitating factor in the myocardial dysfunction. 
The interpretation of data regarding in vivo myocardial function 
during endotoxicosis poses a number of problems, one of these related to 
the sensitivity of the methods used. Many methods may be influenced by 
alterations in cardiac loading or peripheral vascular function (37). 
Recently, Guntheroth et al (41) have observed an early sustained 
reduction in myocardial contractility in dogs, receiving twice the 
LD100 of endotoxin, as 
segment length-pressure 
contractility may not 
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assessed by state-of-the-art techniques (e.g. 
loops). They suggest that the depression in 
be apparent in most preparations in that the 
myocardium is relatively unloaded due to diminished preload and 
afterload. In good agreement with this study, Goldfarb et al (38) also 
noted an early diminished myocardial contractility in dogs that did not 
survive an LD50 dose of endotoxin. They also employed more suitable 
methods for assessing contractility. Presumably the techniques used in 
these studies are not influenced by extra-cardiac modulation of 
contractility and indicate a definite decrease in myocardial function. 
However, others (66) using similar techniques could not find any 
decrease in myocardial function in the dog until the agonal stages of 
endotoxicosis. Therefore, the time course of of the decline in 
myocardial function remains in doubt. 
Assessment of myocardial function in vivo is also influenced by 
the endotoxic milieu, which may contain stimulants and/or depressants 
that mask any change in intrinsic function. Therefore, in vitro studies 
may be important to determining myocardial function in shock. Parker and 
Adams (106) observed myocardial contractile dysfunction in guinea pig 
atria, taken from animals that had received endotoxin 16 hours 
previously, noting a decreased isometric contractile tension and maximum 
rate of tension development in endotoxic tissue as compared to control. 
In contrast, McCaig et al (93) could find no significant contractile, 
electrophysiological, or ultrastructural differences between cardiac 
muscle removed from cats five hours after endotoxin administration and 
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from control cats, not administered endotoxin. Both studies could find 
no direct effect of endotoxin, in vitro, on myocardial function. The 
difference in species, dose of endotoxin, and time course of the 
endotoxicosis make it difficult to assess the relative degree of shock 
in each group, although the severity of endotoxicosis appears to be 
greater in the cats, which showed no myocardial depression. 
B. Factors Influencing Myocardial Performance During Endotoxicosis 
While there is still some controversy over the existence of 
myocardial 
supports 
and late 
dysfunction during endotoxicosis, the majority of evidence 
the view that heart function deteriorates by the intermediate 
stages of endotoxicosis. The proposed mechanisms of the 
dysfunction are numerous and it is apparent that myocardial failure is a 
result of some combination of alterations. 
1. Coronary blood flow and related problems 
Compromised coronary blood flow resulting in a decreased 
myocardial oxygen supply has been demonstrated during endotoxicosis. 
Hinshaw et al (56) suggest that this is due to a decrease in coronary 
perfusion pressure associated with the sustained systemic hypotension 
that develops rapidly after endotoxin administration. Others (10,15) 
have observed a significant increase in coronary vascular resistance and 
a decrease in coronary flow in endotoxin shock. Increases in coronary 
resistance are thought to be mediated by angiotensin II, which 
presumably is released during the hypotensive phase (73). 
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Efforts to preserve myocardial function by augmenting coronary 
blood flow with vasodilators have been equivocal. Bohrs et al (10) were 
not able to increase myocardial function after increasing coronary blood 
flow with dipyridamole, however Peyton et al (110) found that myocardial 
function was improved with nitroprusside administration. The difference 
in response to these substances may be related to their effects on 
preload and afterload. Augmentation of coronary flow by mechanical means 
has been somewhat more successful. Studies by Elkins et al (29) and 
Bruni et al (15) have both demonstrated protection of the myocardium 
when coronary flow was artificially maintained. 
Myocardial dysfunction has been related to myocardial fluid 
disturbances and intra-cardiac ionic imbalances. A study by Mela et al 
(95) demonstrated inter- and intrafiber edema in isolated dog ventricles 
4-7 hours after endotoxin administration. These ventricles were 
considered to be in failure 
pressures. Similar findings 
Hinshaw (57) suggests that 
as determined by elevated end diastolic 
were also reported by Coalson et al (20). 
this edema may exacerbate an increase in 
coronary capillary and myocardial cell membrane permeabilities. 
In addition to, and possibly due to the myocardial edema, 
alterations in ionic concentrations have been indicated in the endotoxic 
heart. Experiments by Hinshaw et al (54) suggest that there is an 
alteration in myocardial calcium handling during endotoxicosis. 
Treatment of dogs with digoxin, a cardiac glycoside which is thought to 
increase intracellular calcium levels, attenuates the myocardial 
dysfunction of endotoxicosis. This may be due to increasing the 
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availability of calcium to the contractile apparatus. 
The appearance of abnormally elevated extracellular potassium 
concentrations secondary to decreases in coronary flow, during 
endotoxicosis may also contribute to myocardial depression (2). High 
extracellular potassium concentrations are known to reduce myocardial 
contractility by accelerating repolarization and shortening the plateau 
of the action potential, which together reduce calcium entry into the 
cell (64). 
2. Humoral factors 
Myocardial function is also thought to be modulated by 
circulating humoral agents. The myocardial depressant factor (MDF) 
reported by Lefer is probably the best known substance of this category. 
According to Lefer (72) MDF is formed by the ischemic splanchnic viscera 
and activated by lysosomal hydrolases primarily from the liver. MDF has 
been demonstrated to directly decrease tension development in isolated 
papillary muscles (72). In additon, Carli et al (17) have demonstrated 
that the serum from septic human patients attenuates the chronotropic 
response to isoproterenol in rat myocytes. There is some evidence that 
MDF depresses fast channel activation in the ventricular myocardium 
(25). In contrast, Hinshaw et al (51) have not been able to detect a 
myocardial depressant factor in endotoxic dogs. This suggests that MDF 
is not produced under all situations or that the concentration of MDF 
that is effective in vitro is not attained in vivo. Therefore the 
significance of MDF production during endotoxicosis is still conjecture. 
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Endogenous opiates may also depress myocardial function. 
Reynolds et al (113) have reversed endotoxin-induced decreases in 
myocardial function by administration of naloxone, an opiate receptor 
antagonist. While most opiate receptors have been identified in the 
central nervous system, there is evidence that high affinity opiate 
receptors exist on myocardial membranes (117). Whether the myocardium is 
the site of endogenous opiate action is yet to be determined. 
Plasma catecholamines (4,63,99,121) and sympathetic discharge 
(105) to the heart are increased during endotoxicosis. There is evidence 
to suggest that high catecholamine concentrations may cause lesions in 
the heart and contribute to myocardial dysfunction (102). The importance 
of this mechanism in endotoxicosis has not been determined. 
Histamine release is an early event in endotoxin shock, the 
degree being dependent upon the dose of endotoxin (133). Blood histamine 
levels have been demonstrated to be inversely correlated with survival 
in rats (116). Treatment of endotoxic animals with antihistamines 
protects myocardial function (68). However, the depression of myocardial 
function by histamine does not appear to be a direct effect but rather 
is mediated by the decrease in coronary blood produced by histamine 
(109). 
Two other mediators produced during endotoxicosis are also 
gaining attention in regards to their possible cardiovascular effects. 
Leukotrienes, which are metabolites of arachidonic acid and related to 
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prostaglandins, are thought to increase in plasma during anaphylaxis and 
septic shock (42). Since leukotrienes are reported to depress myocardial 
contractility in vitro (75), they may contribute to the myocardial 
depression evident in endotoxicosis, however this is merely speculative. 
The macrophage mediator, interleukin-1, is also released during 
infection and appears to have multiple biologic activities (28). Whether 
this substance interacts with the myocardium to any significant extent 
is yet to be determined. 
The direct effects of endotoxin on myocardial function have also 
been studied. In vivo studies have usually been unable to to show a 
direct effect of endotoxin (52). The in vitro effects of endotoxin on 
the heart have been non existent for the most part (93,106) although a 
few studies have indicated that endotoxin influences some myocardial 
metabolic variables and subcellular organelles (69,83). 
3. Subcellular derangements 
Reductions in myocardial function, regardless of the external 
stimuli, are ultimately related to activation and function of the 
contractile apparatus. McCaig and Parrat (94) demonstrated that 
endotoxic cat hearts are not as sensitive to increasing extracellular 
calcium concentrations as control hearts. Likewise, Krause and Hess (69) 
have demonstrated a decrease in canine sarcoplasmic reticulum (SR) 
ca+2-ATPase activity and calcium uptake rate after in vivo 
administration of endotoxin. This would especially affect the rate of 
relaxation of myocardial muscle. In addition to SR changes, myofibrillar 
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ATPase activity was also significantly decreased in the same model. 
Failure of the sarcoplasmic reticulum to accumulate calcium would 
increase cytosolic concentrations and thereby stimulate mitochondrial 
calcium sequestration (48). The increase in mitochondrial calcium 
concentration would then depress ATP production and decrease 
intracellular ATP concentrations. Mela et al (95) found no changes in 
mitochondrial energy producton in endotoxic dog hearts although there 
were some ultrastructural abnormalities. The data from Krause and Hess 
(69) suggests that elevated intracellular concentrations of calcium are 
deleterious to myocardial function. In contrast to these data, studies 
by Hinshaw et al (54) and Somani and Saini (119) indicated that 
increasing intracellular levels of calcium will preserve myocardial 
function. The differences between Krause and Hess and these other groups 
are not readily apparent at this time, although it may be a matter of 
which calcium handling process in the myofibril is most affected during 
the endotoxic insult. 
Sarcolemmal membrane alterations have also been demonstrated. 
Cardiac electrophysiological parameters are somewhat modified during 
exposure to septic serum as evidenced by depressed action potential 
amplitude, duration, resting membrane potential, upstroke velocity in 
dog heart membranes (25). Rat hearts show similar depressions except 
that the action potential duration is lenghthened (17). Relevant to this 
data, Ghosh and Liu (33) report that oubain-sensitive sodium pump 
activity is impaired in dog hearts during endotoxin shock as reflected 
by diminished rubidium uptake by heart slices. They have also indicated 
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that the fluidity of the myocardial membrane is modified in the shock 
state (84), which may affect ionic movements across the sarcolemma and 
adenine nucleotide transport in mitochondria. 
c. Sympathetic Nervous System Support of Cardiovascular Function 
Beyond the myriad of extra- and intra-cardiac mechanisms 
contributing to the myocardial dysfunction of sepsis is the hypothesis 
that throughout the phase of progressive depression of myocardial 
contractility, the adrenergic system supports myocardial performance. 
The importance of sympathetic nervous system support is proposed by a 
number of investigators. Solis and Downing (118) reported that infusions 
of isoproterenol were necessary to increase left-ventricular 
performance, in the one hour endotoxic cat, to control levels. 
Similarly, Hinshaw et al (53) found that they could temporarily restore 
function with beta-adrenergic agonists to failing dog hearts in the 
intermediate stages of endotoxicosis. Dogs that are given 
beta-adrenergic receptor blockers early in sepsis (16) or endotoxicosis 
(40) are not able to maintain myocardial function at control levels or 
able to increase function to meet the demands of the shock state. Cats 
that receive alprenolol prior to endotoxin administration had no 
recovery of myocardial contractility and died within 4 to 6 minutes 
(107). In addition, adrenalectomized dogs or rats are more sensitive to 
lethal doses of endotoxin (70,121). 
Concomitant with the apparent requirement for adrenergic support 
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of the myocardium is a generalized increase in sympathoadrenal discharge 
during endotoxicosis (99,105,121). Thus the myocardium is stimulated by 
catecholamines originating from the adrenal medulla or sympathetic nerve 
endings. This activity is elevated throughout the septic or endotoxic 
insult. In theory there are always adequate concentrations of 
catecholamines to support the myocardium. There is evidence, however, 
that sympathetic nerve endings in the heart and the adrenal medulla 
become depleted (104, unpublished observations) at the terminal stages 
of endotoxicosis but that there is still significant release of 
catecholamines at that time as determined by plasma levels (63). 
D. Myocardial Response to Catecholamines During Endotoxicosis 
The response of the myocardium to beta-adrenergic agonists is 
essential to maintenance of myocardial performance and possibly to the 
survival of the endotoxic animal. Paradoxically, the inotropic response 
of the myocardium appears to be depressed in the later stages of sepsis 
or endotoxicosis. Parrat (107) reported that the inotropic and 
chronotropic response to an infusion of norepinephrine or epinephrine to 
cats was markedly reduced 2-3 hours after endotoxin administration. 
Parrat and Winslow (108) also observed attenuated myocardial responses 
to quozadine, a phosphodiesterase inhibitor, in endotoxin shock in the 
cat. Somani and Saini (119) demonstrated that the cardiovascular effects 
of a dopamine infusion were diminished by two hours after endotoxin 
administration in the dog. Archer and associates (1) also reported 
attenuated responses in the isolated working dog heart preparation. Four 
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to six hours after endotoxin administration epinephrine did not restore 
-dP/dt to normal values. However, they failed to show any significant 
change in -dP/dt in response to epinephrine in the control hearts. Data 
from in vivo and isolated heart studies is tempered somewhat by the 
possibility that high levels of endogenous catecholamines may mask the 
effects of exogenous catecholamines. However Sugerman et al (129) found 
that increased serum catecholamine levels of conscious dogs in septic 
shock did not correlate significantly with cardiac index, which implied 
a decreased responsiveness to catecholamines. Additionally, Baghat et al 
(6) observed that left atrial strips from endotoxin-treated guinea pigs, 
suspended in Tyrode's solution, had a reduced sensitvity to 
norepinephrine and tyramine, while responding normally to stretch. This 
data suggests that the phenomenon of decreased responsiveness to 
catecholamines is not due to a factor present in the septic plasma as 
proposed by Carli et al (17) nor is it an artifact due to increased 
plasma catecholamine levels. 
The inotropic effects of beta-adrenergic agonists are mediated 
by intracellular cAMP (101), therefore the decreased responsiveness is 
likely due to some alteration in the beta-adrenergic receptor-adenylate 
cyclase system and/or the processes controlled by this system. There is 
evidence that the beta-receptor-adenylate cyclase system of the dog 
liver is altered during endotoxicosis (32,85), however studies of this 
nature have not been extended to the myocardium. 
McCaig and Parrat (94) suggest that the decreased response to 
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catecholamines is not due to any alteration in the adenylate cyclase 
activating system, but reflects an alteration in calcium-mediated 
mechanisms. Evidence has also been discussed that demonstrates 
contractile apparatus depression. However, the depression in each system 
is not mutually exclusive and together serve to amplify myocardial 
dysfunction in shock. 
directly responsible 
Loss of responsiveness to catecholamines is not 
for decreased myocardial contractility in 
endotoxicosis. Catecholamine-stimulated mechanisms merely serve to delay 
or diminish the dysfunction originated by other lesions. 
Considering the importance of the adrenergic nervous system in 
supporting the myocardium during sepsis or endotoxicosis, experiments to 
define adrenergic input into the heart and to assess the status of the 
beta-adrenergic receptor-adenylate cyclase system are clearly necessary 
for understanding the mechanism of myocardial dysfunction under these 
conditions. 
CHAPTER III 
BETA-ADRENERGIC STIMULATION OF MYOCARDIAL CYCLIC AMP 
IN ENDOTOXIC RATS 
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INTRODUCTION 
Endotoxicosis with ensuing cardiovascular shock is characterized 
by a variety of hemodynamic responses (58). The initial response to an 
endotoxin challenge is a rapidly developing hypotension, decreased 
venous return, and depressed cardiac output. A compensatory period 
usually follows the hypotensive phase where blood pressure returns 
towards normal. Sympathoadrenal homeostatic mechanisms are active during 
this period however adrenergic discharge may not be stimulated solely by 
the systemic hypotension and associated reflex mechanisms (121). 
Depending upon the severity of the insult the animal may recover 
completely or progress to circulatory collapse. 
Jacobson (61) described an "adrenergic theory of shock" whereby 
the sympathetic nervous system is activated as a compensatory mechanism 
in shock to aid in the restoration of blood pressure. Such compensation 
however, results in the sympathetic nervous system becoming overstressed 
which eventually contributes to the pathogenesis of the shock state. 
While this theory is attractive, supporting experimental data are not 
unequivocal. Bhagat et al (7) reported that chemical sympathectomy with 
6-hydroxydopamine did not alter the severity of endotoxin shock in 
monkeys and Trippodo and Traber (132) had similar findings in the dog. 
In contrast, sympathectomy with 6-hydroxydopamine in the rabbit 
protected against the lethality of endotoxin (11). Selective surgical 
denervation of the abdominal viscera or spleen in dogs also protected 
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from the injury or lethality of endotoxic shock (103,141). Thus, the 
pathogenic effects of sympathetic nervous system hyperactivation are not 
global and may be limited to specific organs or tissues. Furthermore, 
there may be a distinction between the degree of pathogenicity of the 
alpha-adrenergic limb of the sympathetic nervous system as compared to 
beta-adrenergic limb. 
Cyclic AMP (cAMP) is the mediator of the beta-adrenergic limb of 
the sympathetic nervous system and regulates many intracellular 
processes related to metabolism and myocardial function (101). The 
effects of endotoxin on cAMP accumulation and adenylate cyclase activity 
have been studied in a number of metabolically active tissues 
(8,35,122). Most recently, Ghosh and Liu (32) have described endotoxin 
attenuation of catecholamine-stimulated adenylate cyclase activity in 
dog liver membranes. Alterations in the hepatic response to 
catecholamines during sepsis has profound effects on the metabolic 
status of the organism and may ultimately determine survival. Likewise, 
adrenergic support of the myocardium is critical during shock. There is 
evidence that the heart has a decreased response to exogenous 
catecholamines during the latter stages of endotoxicosis (1,6,107), 
which contributes to declining myocardial performance. This may be 
related to an inability to generate cAMP in this tissue, similar to that 
seen in the liver. In this regard, the status of myocardial cyclic 
nucleotide 
reported. 
levels during endotoxicosis have not previously been 
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The purpose of the present study was to determine the time 
course of sympathetic nervous system activation and neurotransmitter 
exhaustion 
assess the 
in various tissues of the rat during endotoxicosis and to 
activation of the cAMP generating system in the heart under 
the same conditions. 
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METHODS 
Animal model 
Male Holtzman rats (300-400 g) were used in all experiments. 
Rats were maintained on Wayne Lab Blox and tap water ad libitum for at 
least 7 days after they were received from the supplier (Holtzman Co., 
Madison, WI). Food was available to the animals at all times prior to 
the experiments. 
Endotoxin (S. enteritidis, lipopolysaccharide B) was purchased 
from Difeo Laboratories, Detroit, MI. The same batch of endotoxin 
(#703252) was used for all experiments. Endotoxin was prepared daily in 
0.9% saline. Lightly etherized rats were injected with endotoxin (16.7 
mg/kg) via the dorsal vein of the penis. This dose elicited greater than 
80% lethality within 24 hours. Control rats were injected intravenously 
with 0.9% saline. 
Ventricular Slice Preparation 
Rats were decapitated at the appropriate times and the hearts 
rapidly removed and placed in ice-cold Krebs-Ringer bicarbonate buffer 
(KRB) which contained (mM): NaCl, 118.5; KCl, 4.8; KH2Po4 , 1.2; MgS04 , 
1.2; CaC12 , 3.6; glucose, 5.5; and NaHco3 , 23.8. The KRB was gassed with 
95% 02-5% co2 and and the pH adjusted to 7.4. The ventricles were sliced 
in a cold room with a Stadie-Riggs microtome (Arthur H. Thomas Co., 
Philadelphia, PA) to a thickness of 0.5 mm. Slices were incubated in 
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t d KRB at 37oc, oxygena e pH 7.4, for 15 minutes in a metabolic shaker 
while being continuously gassed with 95% o2-5%Co2 • At the end of the 
incubation period, 100 ul of 2.5 x 10-5M isoproterenol or vehicle (0.1% 
ascorbic acid) was added to the incubation mixture. After 45 sec. the 
slices were removed from from the incubate, blotted dry and frozen 
between brass clamps previously cooled in liquid nitrogen. Tissues were 
stored in liquid nitrogen until processed for cAMP determination. 
Cyclic AMP Assay 
Frozen samples were weighed and placed in 10 volumes of ice-cold 
10% trichloroacetic acid (TCA). Tissues were homogenized at 4°c for 20 
sec. with a Brinkman Polytron at setting 6. The homogenates were 
centrifuged at 1900 x g for 20 min. One ml of supernatant was extracted 
four times with 4 volumes of water-saturated ethyl ether. The extracted 
aqueous phase was frozen and lyophilized. The residue was dissolved in 1 
ml of 50 mM sodium acetate buffer, pH 6.2, and used directly in the 
assay. 
Cyclic AMP was measured by the method of Steiner et al (126). 
Assay kits were purchased from New England Nuclear, Boston, MA. 
Tissue Catecholamine Content 
Rats were killed by decapitation and the hearts, spleens, and 
adrenals rapidly removed and frozen by compression between brass clamps 
previously cooled in liquid nitrogen. Tissues were stored in liquid 
nitrogen until assayed for catecholamines. 
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Norepinephrine and epinephrine content were measured by the 
method of Crout (21). Frozen tissue was weighed and homogenized in 10 ml 
of ice-cold 10% TCA. Homogenates were centrifuged at 1800 x g for 20 
min. Catecholamines were isolated from the protein-free supernatant by 
column chromatography with acid-washed alumina. Recovery of 
catecholamines from the column was routinely 80% efficient; sample 
values are reported as uncorrected for percent recovery. The column 
eluate was analyzed for catecholamines by forming the trihydroxyindole 
derivative of the bioamine and measuring its fluorescent intensity. The 
procedure was automated as described by Jellinek et al (62). 
Glucose Measurement 
Plasma glucose concentration 
oxidase method using a Model 23A 
Instrument Co., Yellow Springs, OH). 
~ Analysis 
was determined by the glucose 
glucose analyzer (Yellow Springs 
Statistical comparison of two groups was performed by an 
independent Student's t test. Comparison of more than two groups was by 
independent analysis of variance. Significant F tests were followed by 
the mean separation technique of least-significant difference. A P value 
<0.05 was considered to be the minimum for statstical significance. 
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RESULTS 
Plasma glucose concentrations, tissue catecholamine contents and 
myocardial cAMP contents are shown in Table I. Plasma glucose levels are 
used as an indicator of the severity of the shock state (30). At one 
hour after endotoxin administration, given levels were more than double 
the control value, however the glucose values declined rapidly and by 4 
hours were significanly less than the control value. 
Splenic norepinephrine levels were significantly decreased in 
the endotoxic rat by two hours and remained at the same level for the 
duration of the experimental period. 
Adrenal norepinephrine content decreased during the endotoxic 
insult, however it was significantly different only at 4 hours. In 
contrast, adrenal epinephrine content was reduced by 1 hour and 
continued to decline throughout 6 hours of endotoxicosis. 
Myocardial norepinephrine remained constant throughout the 
experimental period. Myocardial cAMP levels were significantly reduced 
early in endotoxicosis but were not different from control at the later 
stages. 
A problem in performing such a time course study is that not all 
animals respond to the endotoxic insult with the same rate. Thus, the 
TA.BU: 1. 
TIME COURSE OF ENDOTOXDIIA (5ml\/~ 
TREATMENT 1 Hr. 2 Hrs. 
Plasma Glucose Saline 145.7 :t 6.4(7) 129.4 :t 3.1(7l 
{lllf./dl) * * Et,.,x '82.4 t 22.3(8) 204.7 :t 31.4(10) 
s~.ler ·NE al ne 73' :t 0 1(7) .'llf; :t .J7(6) 
<~ g) * Et x 7( 9 :t . 6(8) .564 :t .04(1C, 
Adrenal NE Saline .41 :t .06(7) .44 :t .04(7) 
(11g/pr) 
Et ox .37 :t .02(7) .45 :t .07(10) 
Adrenal EPI Saline 1.81 :t 0.19(7) 2.26 :t .2(7) 
(11g/pr) * * Etox 1.39 :t 0.11(7) 1.25 :t .12(10) 
Myocardial NE Saline .820 :t .05(7) .825 t .07 (6) 
(11g/g) 
Etox • 794 :t .06(8) .700 :t .04(9) 
Myocardial cAMP Saline 1955 :t 92(7) 1748 :t 32(6) 
(plllOl/g) 
* * Et ox 1488 :t 69(8) 1410 :t 47(9) 
4 Hrs. 
139.4 :t 3.2 (7) 
* 71 4 t 10.8(9) 
.6 4 :t .05(7) 
* 
.5 3 :t .03(8) 
.62 :t .07(6) 
* 
.43 :t .05(8) 
2.15 :t .19(6) 
* 
.63 :t .06(8) 
.752 :t .03(6) 
.795 :t .13(6) 
1655 :t 126(6) 
1563 t 42(8} 
6 Hrs. 
133.3 :t 3.9(7) 
80.1 :t 10. 'I 
.847 :t ,JL. 
.566 :t .o~ i, 
.60 :! .18(7) 
.37 :t .05(10) 
2.1 :t .19(7) 
* 
.40 :! .04(10) 
.805 :! • 06(7) 
.892 :t .07(11) 
1739 1 50(7) 
1585 :t 52 (11) 
VI 
0 
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values determined during the time course reflect the average of animals 
in different states of endotoxicosis and only the survivors at each time 
point are used. Therefore, the changes in the measured variables in 
severely shocked animals may be masked by values from rats that are more 
resistant to the insult. To circumvent this problem, tissues were 
collected from a group of animals when they were in the terminal stage 
of endotoxicosis, regardless of the duration of the endotoxicosis. The 
terminal stage of endotoxicosis was assessed as that time when the 
animal loses the righting reflex. These data are depicted in Table II. 
Plasma glucose concentrations, spleen norepinephrine, adrenal 
norepinephrine and epinephrine, and myocardial norepinephrine contents 
were all significantly diminished in the endotoxic tissues. In addition, 
the cAMP content of the ventricles from endotoxic rats was reduced 19% 
from control. 
Figure 1 shows the isoproterenol-stimulated cAMP content in rat 
ventricular slices 0.5 hours after the IV administration of saline or 
endotoxin. There were no significant differences in either the basal 
levels or stimulated levels of cAMP between control and endotoxic 
animals. At 3 hours after endotoxin administration there was no 
difference in basal levels, however, the isoproterenol-stimulated cAMP 
content in the endotoxic tissue was not greater than basal (Fig 2). 
Cyclic AMP content increases by 23% in 3 hour control tissue stimulated 
by isoproterenol. At the terminal stage of endotoxicosis (approximately 
5 hours after endotoxin administration) tissues from saline-treated 
animals responded to isoproterenol stimulation with a 29% increase in 
TABLE II 
PHYSIOLOGICAL VARIABLES OF FED RATS FOLLOWING IV 
ADMINISTRATION OF SALINE OR ENDOTOXIN 
Saline ( N=8) EI'OX (N=14) 
TIME TO DEATH 330 ±. 40 311 ±. 30 (mins.) 
Plasma Glucose 154 ±. 3 23 ±. 3* 
(mg/dl) 
SPLEEN NE .77 ±. .08 .36 ±. .04* 
(ug/g) 
ADRENAL NE 
.49 ±. .04 .33 ±. .03* 
(ug/pr) 
ADRENAL EPI 2.2 + .1 .41 ±. .07* 
(ug/pr) 
MYOCARDIAL NE .97 ±. .05 .38 ±. .06* 
(ug/g) 
MYOCARDIAL cAMP 2044 ±. 47 1658 ±. 43* (pmol/g) 
*p<0.05 
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Figure 1. 
Cyclic AMP (pmol/g wet weight) content of ventricle slices, 
before and after isoproterenol stimulation (10-6 M), from control or 
treated rats 0.5 hours after saline or endotoxin administration. Each 
bar represents the mean + SEM for 5-7 preparations, each from a 
different rat. 
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34 
~ 0.1%ASCORBIC ACID 
• 10-6M ISOPROTERENOL 
35 
Figure 2. 
Cyclic AMP (pmol/g wet weight) content of ventricle slices, 
before and after isoproterenol (10-6 M) stimulation, from control or 
treated rats 3 hours after saline or endotoxin administration. Each bar 
represents the mean + SEM for 5-6 preparations, each from a different 
rat. 
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Figure 3. 
Cyclic AMP (pmol/ g wet weight) of venticle slices, before and 
isoproterennol ( 10-6 M) stimulation, from control or 
endotoxin-treated :r:-ats at the terminal stage of endotoxicosis. Each bar 
represents the meaan + SEM for 8 preparations, each from a different 
animal. 
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CAMP content, whereas tissue from endotoxic animals failed to respond 
positively. 
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DISCUSSION 
Intense activation of the sympathetic nervous system is 
generally accepted as a manifestation of sepsis and endotoxicosis 
(63,99,105). Sympathetic activity appears to have beneficial circulatory 
and metabolic effects early in endotoxicosis, but as the endotoxicosis 
progresses, continued adrenergic stimulation may become detrimental to 
the survival of the animal (78). Mechanisms which mediate beneficial vs. 
detrimental actions of sympathetic activity have been suggested in a 
number of studies. Increased survival in endotoxicosis followed 
treatment with alpha-adrenergic receptor blockers or surgical 
denervation (77,103), however, beta-adrenergic receptor blockade with 
propranolol significantly decreased time to death in endotoxic rats 
(31). Adrenergic blockade affects both metabolic and cardiovascular 
processes. The predominant action of alpha-adrenergic blockade on the 
cardiovascular system, is to antagonize the vascular effects of 
norepinephrine and epinephrine, whereas beta-blockade interrupts 
adrenergic input to the myocardium. It appears that the alpha-receptor 
mediated mechanisms injurious while beta-receptor mediated 
mechanisms ameliorate the effects of endotoxin. However, both alpha- and 
beta-adrenergic components may have beneficial as well as detrimental 
effects depending on the stage of endotoxicosis or the particular tissue 
being stimulated. 
The data presented in Table I are suggestive of nonuniform 
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activation of nerves to major organs during the endotoxic insult. 
Adrenal stores of epinephrine are depleted early in the endotoxicosis, 
implying intense stimulation of the medulla and a rise in epinephrine 
output. Presumably this results in the markedly elevated plasma 
concentration of epinephrine observed in endotoxic rats (63). Nykiel and 
Glaviano (99) described a similar rise in epinephrine output in 
endotoxic dogs and found that the release was due to a neurogenic 
mechanism that appeared to be activated by a decrease in arterial blood 
pressure. A similar mechanism may be in effect in the rat in that a 
significant hypotension has been observed in the rat within 10 minutes 
after an LD50 dose of endotoxin (63). It is believed that the heart 
undergoes a progressive deterioration during endotoxicosis, however 
sympathetic stimulation via beta-adrenergic receptors appears to augment 
contractility and maintain myocardial performance adequate for the needs 
of the peripheral tissues. Release of excessive amounts of epinephrine 
from the adrenal medulla may be the primary mechanism for the support of 
myocardial contractility during the endotoxic insult. In agreement with 
this concept, Spink et al (121) reported that the lethal course of 
canine endotoxin shock was accelerated in adrenalectomized animals. 
Splenic norepinephrine becomes depleted within two hours after 
the onset of endotoxicosis (Table II). Norepinephrine turnover in the 
spleen during low dose endotoxin has been reported to increase three 
fold (105). This suggests that depletion of norepinephrine is mediated 
by nerve-stimulated release. Pardini et al (104) have also shown 
reuptake to be attenuated in the spleen at the terminal stages of 
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endotoxic shock. If such changes occur earlier in the endotoxicosis, 
this could account for the norepinephrine depletion in the spleen 
observed by 2 hours in the present study. Immediate activation of 
sympathetic fibers to the spleen may be part of the neurogenic response 
to the hypotension that develops soon after endotoxin administration. 
Presuming that the spleen is representative of innervation to the 
peripheral vasculature in other areas, activation of adrenergic fibers 
to this tissue would mediate vaso- and venoconstriction and augment 
return of blood pressure towards normal. However, sustained constriction 
appears to be harmful in that venous return is compromised, due to 
pooling of blood, and certain vascular beds becoming ischemic (50,77). 
Although myocardial norepinephrine is not depleted within six 
hours after endotoxin administration it must be noted that these animals 
are all survivors and have plasma glucose levels well above what may be 
indicative of a shock state (30). Myocardial norepinephrine depletion 
may just be a terminal event as suggested by the data in Table II. 
Sympathetic nerve activity to the heart is presumably increased during 
endotoxicosis (105), and this may be more important for chronotropic and 
dromotropic mechanisms that control cardiac output rather than for 
potentiation of inotropic properties (3), whereby circulating 
epinephrine will have more significant inotropy stimulating properties. 
There is some evidence that sympathetic fibers to the heart are 
differentially controlled from those of the vasomotor system or adrenal 
medulla (137) and recently Hintze and Vatner (59) have described 
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differential peripheral sympathetic activation during hemorrhage. The 
cardiovascular adaptations to endotoxicosis are very similar to those of 
hemorrhage and the sequence of neurotransmitter depletion of the tissues 
in the present study indicate that sympathetic nerve discharge to the 
periphery may have different intensities and times of activation. 
The values of tissue cAMP content of the heart during 
endotoxicosis also raise some interesting questions. Early in 
endotoxicosis the tissue content is lower than control but there is no 
difference between the survivors at 6 hours and saline controls (Table 
I). At the 
significantly 
the in situ 
terminal stages the cAMP content of endotoxic ventricle is 
(19%) lower than control (Table II). The cAMP content in 
ventricle reflects generation as well as degradation of 
cAMP. Therefore, even though there may be an increased production of 
cAMP in the heart during the first few hours of endotoxicosis this may 
not be reflected by tissue levels.This could be explained by the 
interaction of a variety of hormones and mediators, that are released or 
produced as a result of endotoxicosis, with the cAMP-generating system. 
Yelich and Filkins (140) have reported rats to be hyperinsulinemic 
during the first two hours after endotoxin administration. Insulin is 
known to have anti-epinephrine action in adipose tissue and liver by 
increasing phosphodiesterase (PDE) activity in these tissues (39). Thus 
the hyperinsulemia may increase cAMP degradation in the heart although 
production is increased. At the terminal stage of endotoxicosis, plasma 
insulin is near normal (140) and presumably would not have a significant 
effect on PDE activity. Therefore, the decrease in cAMP content at that 
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time is most likely due to a decrease in production. 
We examined the integrity of the beta-adrenergic 
receptor-adenylate cyclase system in the myocardium by using a 
ventricular slice preparation. Three hours after endotoxin 
administration ventricular slices from the endotoxic rats did not show 
increased cAMP in response to isoproterenol-stimulation. Basal levels 
were not different between the groups, suggesting that there was no 
increase in degradation in the endotoxic tissue. The loss of 
responsiveness in the endotoxic tissue could be due to a decrease in 
substrate availability, inhibition of the generating system by an 
endogenous mediator, a lesion in the generating system, or a combination 
of the three. ATP levels in a variety of tissues have been shown to 
decrease in shock or low flow states (19). While the status of 
myocardial energy charge in endotoxicosis has not been reported, 
myocardial hypoperfusion has been noted for some time (10,15,29). 
Depression of ATP levels may occur in the heart during the late stages 
of endotoxicosis, concomitant with the hypoperfusion, thereby decreasing 
substrate available to adenylate cyclase. 
A number of cardiodepressant factors have been reported to be 
produced during sepsis or endotoxicosis (36). Generally these substances 
are thought to have a direct effect on the myocardium, however Carli et 
al (17) have described a product in human septic serum that also 
inhibits the chronotropic stimulatory effects of isoproterenol on rat 
myocardial cells. More recently, the macrophage mediator, interleukin-1, 
has been implicated 
(28). Whether this 
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as contributing to the pathogenesis of infection 
substance has any inhibitory interaction with the 
beta-adrenergic receptor-adenylate cyclase system is yet to be reported. 
A number of studies (1,6,107) have suggested that there is a 
decreased functional responsiveness of the septic or endotoxic 
myocardium to catecholamines. This phenomenon may be related to the 
failure of the endotoxic ventricle to accumulate cAMP. The generation of 
cAMP is a result of catecholamine-beta-adrenergic receptor interactions 
on the myocardial cell membrane and is dependent upon 1) the number of 
available receptors to bind the agonist, 2) the affinity of the receptor 
for agonist, 3) the efficiency of coupling between the receptor and 
adenylate cyclase, and 4) the functional status of the cyclase. Once 
produced, cAMP mediates the phosphorylation of intracellular proteins 
important to the myocardial contractile process. If this system is 
modified by endotoxin or a mediator of endotoxicosis the cAMP production 
may be decreased and the ability of adrenergic stimulation to support 
cardiac contractility compromised. Thus the preservation of 
cardiovascular performance by stimulation of cardiac beta-adrenergic 
receptors in the early stages of endotoxicosis may be a beneficial 
homeostatic mechanism. However the efficiency of this mechanism may 
deteriorate during the development of endotoxic shock. 
The catecholamines that support the myocardium early in 
endotoxicosis may also be responsible for the decreased functional 
responsiveness to catecholamines observed at the terminal stage. The 
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concept of tachyphylaxis or desensititzation is firmly established as a 
catecholamine-induced mechanism in cardiovascular tissue (127). The 
sustained elevated levels of sympathetic nervous system activity to the 
heart in the form of norepinephrine release or circulating epinephrine 
could possibly 
Therefore it 
reach levels high enough to initiate 
is conceivable that the beneficial 
this change. 
effects of 
catecholamines on the heart become detrimental when beta-adrenergic 
receptor stimulation is excessive or sustained. 
The specific role of the sympathetic nervous system in the 
pathogenesis of sepsis or endotoxicosis is not universally accepted and 
the data from the present study leaves many questions unanswered. 
Clearly more studies are needed to determine the stimulus for the 
sympathetic hyperactivation and the relative outflow to the peripheral 
organs and tissues. Additionally the mechanisms by which the seemingly 
beneficial actions of catecholamines become deleterious must be 
elucidated. 
CHAPTER IV 
ALTERATIONS IN BETA-ADRENERGIC STIMULATION 
OF MYOCARDIAL ADENYLATE CYCLASE 
IN ENDOTOXIC RATS 
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INTRODUCTION 
Gram-negative sepsis and the related consequences have been 
documented to be persistent health problems (91) deserving of aggressive 
scientific investigation. Furthermore, recent evidence (71,112,142) has 
linked bacterial endotoxins to the clinical expression of sepsis, which 
supports the use of the endotoxic animal model for studying the basic 
pathophysiologic process of septic shock. 
Myocardial dysfunction is generally accepted as a manifestation 
of sepsis and endotoxicosis (58,76), but the time course and mechanisms 
of failure are not readily agreed upon. Some investigators have observed 
myocardial depression as soon as one hour after endotoxin administration 
(38,41) whereas others have not seen changes for five or six hours after 
endotoxin (53) and still others find myocardial failure is only a 
terminal event (66). It has been suggested (40) that the myocardium of 
endotoxic animals may undergo a slow but progessive deterioration that 
is masked by increased sympathetic drive. Indeed sympathetic nervous 
system activity is markedly increased during endotoxicosis (105) or 
sepsis (4) and it has been shown that myocardial function is depressed 
further during endotoxicosis or sepsis when beta-adrenergic receptor 
antagonists are administered (16,40). Therefore it appears that 
beta-adrenergic stimulation is important in supporting cardiac function 
during sepsis. 
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Reduced responsiveness to catecholamines in the latter stages of 
endotoxicosis has been observed by a number of investigators. Parrat 
(107) reported that the effects of epinephrine and norepinephrine 
infusions on blood pressure, heart rate, cardiac output, myocardial 
blood flow and left ventricular dP/dt were markedly reduced 2-3 hours max 
after endotoxin administration to anesthetized cats. Recovery of the 
response to norepinephrine was associated with a general circulatory 
improvement. Bhagat et al (6) observed a reduced inotropic response to 
norepinephrine in left atrial strips from endotoxin-treated guinea pigs. 
Archer and associates found that four to six hours after endotoxin 
treatment norepinephrine infusions did not restore positive or negative 
dP/dt values to normal in the isolated dog heart. Recently, Sugerman and 
co-workers (129) have noted that increased serum catecholamine levels of 
septic dogs did not correlate significantly with cardiac index or 
systemic vascular resistance. The reduction in response to 
catecholamines in all of these studies appears to unmask myocardial 
deterioration that may manifest in circulatory collapse. 
The mechanisms of such changes in responsiveness are unknown. A 
number of investigators have proposed the existence of a myocardial 
depressant factor (MDF) in the serum of septic or endotoxic subjects 
(17,74). This substance appears to attenuate the myocardial response to 
catecholamines in vitro (17). Other investigators (55) have not been 
able to observe the proposed actions of an MDF-type substance in their 
preparations and therefore the MDF theory does not have unanimous 
support. Since it is known that adrenergic stimulation of myocardial 
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contractility is mediated by the beta-adrenergic receptor-adenylate 
cyclase system and that this system has been observed to be modulated 
under a number of physiological or pathophysiological situations (45), 
the adrenergic mechanism itself may be the point of alteration. A 
modification of any of the components of the system could result in a 
decreased response to catecholamines. Preliminary studies (114) have 
shown a reduced tissue content of cAMP in response to isoproterenol 
stimulation in rat ventricular slices 5 hours after in vivo endotoxin 
administration. This may be the result of a decrease in cAMP generation 
or increased degradation of cAMP. In either case augmentation of 
myocardial contractility would be compromised. 
The purpose of the present study was to examine myocardial 
adenylate cyclase activation via beta-adrenergic receptors during 
various stages of endotoxicosis in the rat and to determine if changes 
in responsiveness develop in this system. Our data suggest that the 
integrity of beta-adrenergic receptor-adenylate cyclase system is 
compromised in the late stages of endotoxicosis and that this may 
correlate with myocardial failure which is characteristic of endotoxin 
shock. 
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METHODS 
Animal Model 
Healthy male Holtzman rats (Holtzman Company, Madison, WI) 
weighing between 300 and 400 g were used in this study. Rats were housed 
in wire-mesh cages at 22° C ambient temperature with a 12-hr light dark 
cycle and provided with food (Wayne Lab Blox) and water ad lib. Rats 
were kept in this manner for at least one week prior to use in 
experimental protocols. 
single 
Endotoxin (Difeo 
batch (703252) 
Laboratories, Detroit, MI) was purchased as a 
of Boivin lipopolysaccharide from Salmonella 
enteritidis. Endotoxin for injection was prepared fresh daily in 0.9% 
saline (5 mg/ml). Rats were lightly anesthetized with ether and injected 
with endotoxin (16.7 mg/kg) intravenously via the dorsal vein of the 
penis. Previous experiments had shown this dose of endotoxin to result 
in a 90% lethality at 24 hr. Control animals were injected intravenously 
with 0.9% saline. Animals were sacrificed by decapitation and hearts 
were rapidly removed and perfused with ice-cold saline through the aorta 
to remove blood. Chilled hearts were trimmed of adipose tissue, large 
vessels and atria and the ventricles were frozen by compression between 
brass tongs previously cooled in liquid nitrogen. Frozen tissue was 
stored in liquid nitrogen until assayed. 
Experiments were designed to study myocardial adenylate cyclase 
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activity at various stages of endotoxicosis. The majority of rats 
subjected to the dose of endotoxin used in this protocol died within 6 
hours, therfore rats were killed at early (0.5) or middle (3 hours) 
points in the time period or when the animals were near death. The 
terminal stage of endotoxicosis is characterized by marked hypoglycemia 
and lactacidemia (58) and is considered as that time when the animal 
loses its righting reflex. Control animals were time-matched such that 
each time an endotoxic rat succumbed a saline-treated control was 
sacrificed. 
Membrane Preparation 
Frozen ventricle (approximately 150 mg) was weighed, minced and 
placed in 10 volumes of ice-cold grinding buffer (5 mM Tris-HCl, 1 mM 
MgC12 , 250 mM sucrose, pH 7.4). The tissue was allowed to thaw then 
homogenized with two 15-sec bursts with a 15-sec cooling interval, using 
a Tekmar Tissumizer set at speed 7 with probe generator STD100EN (Tekmar 
Co., Cincinnati, OH). The homogenate was centrifuged at 48,000 x g for 
15 min in a Sorvall RC-5 (Dupont Co., Wilmington, DE). The supernatant 
was discarded and the pellet resusperided in 20 volumes of suspension 
buffer (75 mM Tris-HCl, 15mM MgC12 , pH 7.53 at 25 ° C). The suspension 
was centrifuged and resuspended twice more. The final pellet was 
suspended in 20 vol of the suspension buffer and filtered through four 
layers of surgical gauze. The final membrane protein concentration was 
approximately 2.0 mg of protein/ml. 
Protein concentration of the membrane suspension was measured by 
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the Bradford method (13) using bovine serum albumin as the standard. 
~enylate Cyclase Activity 
This procedure was based on the methods of O'Connor et al (100) 
with some modification. Approximately 75 ug of membrane protein were 
added to a total volume of 150 ul of 75 mM Tris-HCl (pH 7.4), 8 mM KCl, 
7.5 mM theophylline, 0.4 mM dithiothreitol, 0.4 mg/ml bovine serum 
albumin, 0.7 mM EGTA, 6 mM MgC12 , 1 mM ATP, 2.5 mM creatine phosphate, 
o.075 mg/ml creatine phosphokinase, and 1.0 mM ascorbic acid in a 1.5 ml 
polyethylene microcentrifuge tube (Sarstedt, Princeton, NJ). The 
mixtures were incubated for 20 min at 30° C. In certain assay conditions 
either 8 mM NaF, 10-4 M Gpp(NH)p (guanylyl-imidodiphosphate), 10-4 M GTP 
(guanosine-triphosphate), or 10-4 GTP plus 10-9 to 10-3 M (-) 
isoproterenol were included. After the incubation period the reaction 
was terminated by the addition of 700 ul cold 1 mM EDTA, 50 mM sodium 
acetate (pH 7.2). The mixtures were centrifuged for 10 min at 10,000 x g 
in an Eppendorf Model 5414 Microfuge (Brinkmann Inst. Co., Westbury, NY) 
and the supernatant was decanted into 12x75 mm glass tubes and stored at 
-20° c until assayed for cAMP. Cyclic AMP was measured by 
radioimmunoassy using a kit obtained from Becton Dickinson 
Immunodiagnostics (Orangeburg, NY). All other reagents were purchased 
from Sigma Chemical Co. (St. Louis, MO). 
Statistical Analysis 
The maximum stimulated adenylate cyclase activity and the 
concentration of isoproterenol required to half maximally stimulate 
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adenylate cyclase activtiy (Ec50 ) for each assay were determined using 
the ALLFIT program (22). Control and endotoxic values at each stage were 
compared by unpaired Student's t test. When differences in Ec50 were 
observed, lines were also compared by analysis of covariance. 
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RESULTS 
Various pharmacological probes were employed to stimulate 
adenylate cyclase activity. Figure 1 shows isoproterenol stimulation of 
rat heart ventricular membrane adenylate cyclase after 0.5 hours of 
endotoxicosis. There are no significant differences between baseline 
values for control and endotoxin treated animals or at any concentration 
of isoproterenol above 10-8 Mas compared by unpaired Student's t-test. 
There are small but significant differences in cyclase activation at 
10-10 M to 10-8 M isoproterenol. In each case studied the control value 
is greater than the experimental value. 
Isoproterenol stimulation of adenylate cyclase activity three 
hours after endotoxin administration is shown in figure 2. There are no 
significant differences between basal levels or any degree of 
isoproterenol stimulation. 
At the terminal stage of endotoxicosis, when the rats are in a 
shock state, the basal levels of adenylate cyclase activity are not 
different. Mean isoproterenol-stimulated cyclase activity is markedly 
different from 10-8 M to 10-5 M however the values reach statistical 
significance only at a concentration of 10-7 M (fig. 3). 
In Table 1 the concentration {-log molar) of isoproterenol 
required to stimulate adenylate cyclase half-maximally (Ec50 ) and the 
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Figure 1. 
Effect of isoproterenol on adenylate cyclase activity in 
membranes derived from 
endotoxin-treated rats 
ventricular 
0.5 hours 
myocardium from control and 
after saline or endotoxin 
administration. Each point represents the mean + SEM of 4-5 preparation, 
each from a dil'ferent aniruai.. 
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Figure 2. 
Effect of isoproterenol on adenylate cyclase activity in 
membranes derived from ventricular myocardium from control and 
endotoxin-treated rats 3 hours after administration of saline or 
endotoxin. Each point represents the mean + SEM from 5-6 preparations, 
each from a different animal. 
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Figure 3. 
Effect of isoproterenol on adenylate cyclase activity in 
membranes derived from ventricular myocardium from control and 
endotoxin-treated rats at ~he terminal stage of endotoxicosis. Each 
point represents the mean + SEM of 5-6 preparations, each from a 
different animal. 
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TABLE I. ADENYLATE CYCLASE ACTIVITY 
Stage of endotoxicosis 
Control 
0.5 HOURS 
Endo toxin 
Control 
3.0 HOURS 
Endotoxin 
Control 
TERMINAL 
Endotoxin 
EC50 
(-log M ISO) 
7.08+0.32 
7.01+0.08 
7.26+0.13 
6.93+0.2 
7.72+0.11 
* 
7 .19+0 .11 
vmax 
(pmol cAMP/min/mg) 
117.5+18.9 
90.8+10.0 
141.6+3.5 
143.2+11.o 
104.3+16.5 
87.0+5.6 
* p<0.05 
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maximum stimulation (V ) are compared max 
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by unpaired t-test at each 
stage of endotoxicosis. The values presented are means of data from 
individual experiments. Values for each experiment were generated by the 
ALLFIT program. The Ec50 for the endotoxin group is not significantly 
different from control at 0.5 or 3 hours, although the Ec50 is somewhat 
greater for both control groups. At these times there is no difference 
in Vmax• At the terminal stage the EC50 is shifted significantly to the 
right in the endotoxin animal as compared to control. The values 
(7.19+0.11 vs. 7.72+0.11, -log isoproterenol concentration or 7.54 x 
10-8 M vs. 2.14 x10-8 M) represent a greater than threefold increase in 
the concentration of isoproterenol necessary to stimulate adenylate 
cyclase half-maximally in the terminal stages. Since this shift was 
observed only in the terminal group the data at that stage was also 
analyzed by analysis of covariance. This method analyzes the linear part 
of each dose response curve and compares lines with similar slopes. The 
dose response curves were shown to be significantly different by this 
method at terminal endotoxicosis. The Vmax is not significantly 
different in the terminal groups, however the mean values are lower in 
the endotoxic animal. 
Adenylate cyclase was also stimulated in ventricular membranes 
with NaF or Gpp(NH)p, substances that activate cyclase at some point 
distal to the receptor, presumably via binding to the guanine-nucleotide 
regulatory protein. There was no difference in the ability of either NaF 
(fig. 4) or Gpp(NH)p (fig. 5) to stimulate control or endotoxic membrane 
cyclase at any stage of endotoxicosis. 
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Figure 4. 
Effect of NaF (7 mM) on adenylate cyclase activity in membranes 
derived from ventricular myocardium from control and endotoxin treated 
rats 0.5, and 3 hours after saline or endotoxin administration or at the 
terminal stage of endotoxicosis. Each bar represents the mean + SEM of 
5-6 preparations, each from a different animal. 
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Figure 5. 
Effect of guanylylimidodiphosphate (GppNHp) on adenylate cylcase 
activity in membranes derived from ventricular myocardium from control 
and endotoxin-treated rats at 0.5 and 3 hours after salin or endotoxin 
administration or at the terminal stage of endotoxicosis. Each bar 
represents the mean + SEM of 5-6 preparations, each from a different 
animal. 
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DISCUSSION 
The data presented in this study demonstrate that the 
beta-adrenergic receptor-adenylate cyclase system remains intact in the 
rat ventricle until the terminal stage of endotoxicosis. During the 
early stages of endotoxicosis there is no evidence for a lesion at any 
point in the system, however at the later stage there appears to be 
modification of at least one component or interaction between the 
components. It is currently believed that there are three major 
components of the adenylate cyclase activating system: the receptor, the 
catalytic moiety of the enzyme, and the guanine-nucleotide regulatory 
protein which acts as a transducer between receptor occupancy and enzyme 
activation (82). An alteration of any component of this system would 
result in an attenuated production of cAMP. Cyclic AMP is considered the 
prime mediator of adrenergic stimulation of contractility in the heart 
(101). If the production of cAMP in response to adrenergic agonists was 
compromised it would severely limit the ability of the sympathetic 
nervous system to support myocardial function during stress. 
To determine if changes in the catalytic moiety of the enzyme or 
interaction of the guanine nucleotide regulatory protein and catalytic 
moiety occured during the endotoxicosis, membrane preparations were 
challenged with 8 mM NaF or 0.1 mM Gpp(NH)p. The stimulation of 
adenylate cyclase activity by NaF or Gpp(NH)p is a result of binding to 
the guanine nucleotide regulatory protein. This enhances the association 
69 
of the protein with the catalytic moiety and thus catalytic activity is 
augmented. The concentrations of NaF and Gpp(NH)p used in this study are 
within the range that would maximally stimulate cyclase activity. Since 
there was no difference at any time during the endotoxicosis between 
control and endotoxic membrane response to either substance, this 
suggests that the interaction between the guanine nucleotide regulatory 
protein and the catalytic moiety is intact. This also implies that the 
catalytic unit can be maximally activated in the endotoxic tissue. 
Direct stimulation of the catalytic unit by forskolin might better 
reflect the state of the enzyme. However, since there were no 
differences in Vmax between control and endotoxic animals when either 
NaF or Gpp(NH)p were used, activation by forskolin would not give any 
further information. 
Stimulation of adenylate cyclase activity with adrenergic 
agonists involves all the components of the system (127). To assess 
agonist activation of adenylate cyclase, membrane preparations were 
incubated with varying concentrations of isoproterenol. At the terminal 
stage of endotoxicosis the dose response curve to isoproterenol is 
shifted to the right without any significant loss in maximum 
stimulation. This suggests that some change in the receptor-agonist 
interaction or receptor-guanine nucleotide regulatory protein 
association has occurred. Receptor number and affinty for ligand have 
been observed to decrease in various physiological or pathophysiological 
situations (45). The possibility of one or both of these happening in 
the heart during endotoxicosis cannot be discounted. Liu and Ghosh (85) 
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have reported that endotoxin administration in vivo (1 mg/kg) decreased 
both the binding affinity of radiolabeled antagonist and the density of 
beta-adrenergic receptors in dog liver plasma membranes at 2 hours after 
the injection. Isoproterenol-stimulated adenylate cyclase was also 
inhibited in the same tissues (32). Fluoride and guanine-nucleotide 
activation 
effects of 
were similarly depressed in this tissue. In addition, these 
endotoxin on receptors and adenylate cyclase were also 
observed in in vitro experiments. 
The present data suggest that the coupling of receptor to 
adenylate cyclase may be altered, regardless of whether there are 
alterations in the number of receptors or receptor affinity for 
antagonists in the myocardium. The interaction of beta-adrenergic 
receptors with adenylate cyclase may be dependent upon the fluidity of 
membrane of which they are a part. Hirata et al (60) have shown that 
beta-receptor agonists 
phosphatidylethanolamine 
membrane fluidity is 
increase phospholipid 
is converted to 
methylation, such that 
phosphatidylcholine, and 
enhanced. This is associated with an increased 
coupling of receptor with cyclase and production of cAMP. Furthermore 
Limas (79) has shown phospholipid methylation to regulate the number of 
beta-adrenergic receptors in myocardial membranes. Liu and his 
colleagues have studied membrane fludity of myocardial and hepatic 
membranes exposed to endotoxin in vivo or in vitro (84,86). Their data 
shows a increase in phospholipase A activity in both endotoxic membranes 
as compared to their respective controls. This is associated with an 
increase in phosphatidylcholine hydrolysis and decreased membrane 
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fluidity. It appears that the endotoxin may directly stimulate 
phospholipase activity in these membranes. The decrease in fluidity is 
thought to be at least partially responsible for decreased adenylate 
cyclase activity in liver plasma membranes. In the present study 
alterations in membrane fluidity would have to be considered as a factor 
in the decreased sensitivity of cyclase activation in the latter stages 
of endotoxicosis. 
The myocardium is known to lose responsiveness to catecholamines 
during exposure to partial or full agonists. This tachyphylaxis or 
desensitization may be the result of receptor down regulation or 
uncoupling of the receptor from adenylate cyclase (127). Short term 
exposure (a few hours or less) of myocardial tissue to elevated levels 
of catecholamines in vivo or in vitro have been shown to attenuate 
contractile and adenylate cyclase responses to catecholamines (90,138) 
without changes in receptor number or affinity. Chronic catecholamine 
administration (days) in vivo is associated with down-regulation of 
receptors as well attenuated cyclase response to agonists (18). 
Jones and Romano (63) have reported plasma concentrations of 
norepinephrine and epinephrine to increase 40 and 100 times, 
respectively , by the terminal stages of endotoxicosis in rats receiving 
the same dose of endotoxin as the present study. The supranormal levels 
of norepinephrine are apparently due to increased nerve stimulated 
release (105). The data of Kopin et al (67) suggest that in conditions 
of nerve-stimulated release the concentration of norepinephrine at the 
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post-synaptic membrane will be considerably higher than that measured in 
the plasma. Therefore plasma levels in the Jones and Romano (63) study 
underestimate the levels at the receptor. While these concentrations 
represent a significant increase above baseline levels the 
concentrations at the beta-receptor (approximately 10-7 M), as 
calculated using the Kopin work, are not of the same magnitude as most 
of the concentrations used in in vitro or infusion studies that have 
observed the desensitization phenomenon (43). In this respect the effect 
of endogenous catecholamine elevations may not be to the same extent or 
follow the same time course as those studies in which desensitization 
has been demonstrated with exogenous catecholamines. In the present 
study agonist concentration at the beta-receptors may be increased 
enough for the duration of the endotoxicosis (5 hours) to cause a modest 
desensitization of these receptors in the shocked rat myocardium and 
this could account for the rightward shift in the adenylate cyclase dose 
response curve to isoproterenol. If the total number of receptors is not 
changed this could account for similar maximum responses in both 
tissues. Although there is no significant difference in maximum cyclase 
activation values at the terminal stage, the mean values of the 
endotoxic group are much lower. It is possible that the difference could 
reach significance if the time of the myocardial exposure to 
catecholamines was lengthened. 
The mechanism of receptor uncoupling during agonist-specif ic 
desensitization is yet to be be determined, however decreasing membrane 
fluidity has been suggested as a possible mechanism. Quinacrine, a 
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phospholipase A inhibitor, has been observed to attenuate the loss of 
receptors during chronic isoproterenol administration (131). Others have 
found an altered phosphorylated form of the receptor after chronic 
exposure to catecholamines that may account for problems of coupling to 
the cyclase (124). Recently, Bobik and Little (9) have found that heart 
cells treated with phosphodiesterase inhibitors manifest signs of 
desensitization which suggests that receptor alterations are cAMP 
mediated. 
Regardless of the mechanism contributing to decreased production 
of cAMP, data presented here suggest that the decreased functional 
responsiveness to catecholamines during endotoxicosis observed in a 
number of laboratories is based on alterations at the cellular level. 
Myocardial dysfunction during endotoxicosis appears to be the result of 
a number of abnormalities. Coronary hypoperfusion, intracardiac ionic 
imbalances, depression in the ability of the sarcoplasmic reticulum to 
sequester calcium and depression of contractile protein function are all 
believed to contribute to the failure (49). While the loss of adrenergic 
responsiveness is not likely to be the sole cause of the myocardial 
failure of endotoxicosis, the loss of adrenergic support would 
exacerbate the decline in myocardial function (40,118). Protection of 
beta-adrenergic receptors may be of therapeutic value during episodes of 
clinical sepsis. 
In conclusion, the loss of sensitivity of adenylate cylase 
activation to isoproterenol stimulation in the endotoxic rat heart 
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appears to be an uncoupling event. However to better understand the 
mechanisms involved, future experiments should evaluate the binding 
characteristics of beta-adrenergic agonists and antagonists in the heart 
at various stages of endotoxicosis. 
CHAPTER V 
CHARACTERISTICS OF MYOCARDIAL BETA-ADRENERGIC RECEPTORS 
DURING ENDOTOXICOSIS IN THE RAT 
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INTRODUCTION 
Sympathetic nervous system activity is known to support the 
cardiovascular and metabolic adjustments to stress. However prolonged 
periods of elevated sympathetic activity may be detrimental and 
contribute to the pathogenesis of the stress state. Sepsis and 
endotoxicosis are conditions in which augmented sympathetic nervous 
system activity is at the same time both necessary for and deleterious 
to cardiovascular regulation of homeostasis. It appears that support is 
extended mainly through the beta-adrenergic limb of the system and not 
the alpha-adrenergic component. Beta-adrenergic blockade during 
endotoxicosis has been shown to increase lethality in rats (31), whereas 
alpha-adrenergic blockade or selective denervation protected against the 
lethality of endotoxic shock in both rats and dogs (31,77). 
Beta-adrenergic receptor stimulation has been shown to be particularly 
important to maintaining myocardial performance during sepsis or 
endotoxicosis since blockade of myocardial beta-receptors severely 
compromises myocardial function (40,16). 
Studies from a number of laboratories have determined that the 
response to catecholamines is decreased in the latter stages of 
endotoxicosis (1,6,107). With the apparent myocardial requirement for 
sympathetic nervous 
endotoxicosis it is 
system support 
significant that 
of the myocardium during 
the myocardial response to 
catecholamine stimulation is diminished. There has been no attempt in 
any previous study to determine the mechanism of the attenuated 
responsiveness. Possible explanations for the decreased responsiveness 
are: 1) inability of the heart muscle to respond to inotropic stimuli of 
any type; 2) high existing levels of plasma catecholamines, which could 
mask the response to exogenous agents (in vivo studies); or 3) 
alterations of the beta-adrenergic effector system. 
It has previously been reported that isoproterenol-stimulated 
CAMP accumulation in rat ventricular slices was attenuated in the 
terminal stage of endotoxicosis (114) and that there is a decreased 
sensitivity of adenylate cyclase to isoproterenol stimulation at the 
same time (115). These changes do not appear to be due to a modification 
of the enzyme itself or to deterioration of activation via the guanine 
nucleotide regulatory protein. This leaves the receptor as the possible 
point of the lesion. Therefore the purpose of this study was to assess 
myocardial beta-receptor characteristics at various stages of 
endotoxicosis in the rat using radioligand binding techniques. 
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METHODS 
Animal Model 
Healthy male Holtzman rats (Holtzman Company, Madison, WI) 
weighing between 300 and 400 g were used in this study. Rats were housed 
in wire-mesh cages at 22° C ambient temperature with a 12-hr light-dark 
cycle and provided with food (Wayne Lab Blox) and water ad libitum. 
Rats were kept in this manner for at least one week prior to use in 
experimental protocols. 
Endotoxin (Difeo Laboratories, Detroit, MI) was purchased as a 
single batch (703252) of Boivin lipopolysaccharide from Salmonella 
enteritidis. The endotoxin injectate was prepared fresh daily in 0.9% 
saline (5 mg/ml). Rats were lightly anesthetized with ether and injected 
with endotoxin (16.7 mg/kg) intravenously via the dorsal vein of the 
penis. Previous experiments had shown this dose of endotoxin to result 
in a 90% lethality at 24 hr. Control animals were injected intravenously 
with 0.9% saline. Animals were sacrificed by decapitation 0.5 and 3 
hours after endotoxin administration or in the terminal stages of 
endotoxicosis as determined by loss of the righting reflex. Each time an 
endotoxic animal was killed a control animal was also sacrificed. Hearts 
were rapidly removed and perfused with ice-cold saline through the aorta 
to remove blood. Chilled hearts were trimmed of adipose tissue, large 
vessels and atria and the ventricles were frozen by compression between 
brass clamps previously cooled in liquid nitrogen. Frozen tissue was 
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stored in liquid nitrogen until assayed. 
Membrane Preparation 
Suitable cardiac membrane preparations were prepared as 
previously described by Baker et al (3) with minor modification. Frozen 
ventricles were weighed, minced and placed in 10 ml of ice-cold grinding 
buffer (5 mM Tris-HCl, 1 mM MgC12 , 250 mM sucrose, pH 7.4). The tissue 
was allowed to thaw then homogenized with two 15-sec bursts with a 
15-sec cooling interval, using a Tekmar Tissumizer set at speed 7.5 with 
probe generator STD100EN (Tekmar Co., Cincinnati, OH). The homogenizer 
was rinsed with 5 ml of grinding buffer and this was added to the 
homogenate. An equal volume (15 ml) of cold 1 M KCl was added to the 
homogenate and the mixture was continuously stirred on ice for 15 min. 
The homogenate was centrifuged at 48,000 x g for 15 min in a Sorvall 
RC-5 (Dupont Co., Wilmington, DE). The supernatant was discarded and the 
pellet resuspended in 25 volumes of suspension buffer (75 mM Tris-HCl, 
15mM MgC12 , pH 7.53 at 25 ° C). The suspension was centrifuged and 
resuspended twice more. The final pellet was suspended in 25 vol of the 
suspension buffer and filtered through four layers of surgical gauze. 
The final membrane concentration was 0.8-1.6 mg/ml. 
Protein concentration of the membrane suspension was measured by 
the Bradford method (13) using bovine serum albumin as the standard. DHA 
was prepared in 0.1 mM ascorbic acid. Isoproterenol was prepared in 1 mM 
HCl/0.1 mM ascorbic acid. 
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~inding Experiments 
Binding assays were based on the methods of Lurie et al (88) 
with some modification. In the saturation experiments 250 ul aliquots of 
the membrane preparation were incubated with increasing concentrations 
of (3-H)-dihydroalprenolol (DHA, sp. act. 35.6 Ci/mmol) with or without 
(-) isoproterenol 10-3 M in a final volume of 500 ul of incubation 
buffer (75 mM Tris-HCl, 15 mM MgC12 , 1 mM ascorbic acid, pH 7.4); the 
final concentration of DHA ranged from 0.3 to 17.0 nM. The mixtures were 
incubated at 30° C for 30 min. At the end of the incubation period 
binding was terminated by adding 4 ml of ice-cold buffer (75 mM 
Tris-HCl, 15 mM MgC12 , pH 7.4) to the mixtures then filtering on Whatman 
GF/C filter papers using a Brandel Cell Harvester (Gaithersburg, MD). 
Each filter was washed with 6-9 ml of buffer. The filters were placed in 
5 ml mini-scintillation vials (RPI, Mt. Prospect, IL) and allowed to 
dry. The vials were filled with 3.5 ml of scintillation fluid (3a70, 
RPI) and the radioactivity was counted in a Packard Tri-Carb 460 
(Packard Instrument Co., Downers Grove, IL). Specific binding was 
determined by subtracting DHA binding in the presence of 10-3 M (-) 
isoproterenol from DHA binding in the absence of isoproterenol. Specific 
binding was generally 60-65% of total binding at the Kd for DHA. 
Saturation data were analyzed using non-linear regression with 
weighting. The use of this method was previously reported by Lurie et al 
(88) and a listing of the program was graciously supplied by Dr. Michael 
R. Bristow. 
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In competition studies aliquots of membrane protein were 
incubated with a single concentration of DHA (2-4 nM) and 15 increasing 
concentrations of (-) isoproterenol (10-10 M to 10-3 M). The assay was 
then performed exactly as the saturation experiments. 
Competition data were analyzed by two methods. The concentration 
of isoproterenol required to inhibit 50% of DHA binding (Ic50 ) and the 
slope factor (pseudo-Hill coefficient) of the competition curve were 
derived from a four-parameter logistic equation, the ALLFIT program of 
DeLean et al (22). Where differences in the slope factors of the 
competition curves existed between endotoxic and control membranes the 
curves were modelled to a one or two state fit using LIGAND, the 
non-linear curve modelling program of Munson and Rodbard (98). 
(3H) dihydroalprenolol was purchased from New England Nuclear 
(Boston, MA). All other reagents were purchased from Sigma Chemical co. 
(St. Louis, MO). 
Statistcal Analysis 
Student's t test or a one way analysis of variance were used, 
when appropriate, for the statistical analysis of the data. Determining 
goodness of fit for a binding model was based on the "extra sum of 
squares" principle (98). A two state model was accepted only if it 
significantly improved the fit over a one state model. 
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RESULTS 
Saturation Binding Assays 
General beta-adrenergic receptor characteristics were determined 
by performing saturation 
(3H)dihydroalprenolol. Figures 
grouped experiments 0.5 and 
binding assays using the antagonist 
1, 2 and 3 depict binding data from 
3.0 hours after endotoxin or saline 
administration or 
specific binding 
during the terminal stages of endotoxicosis. Mean 
at each concentration of DHA for control and 
endotoxin-treated animals are shown on each graph. The inset of each 
graph contains average data represented as Scatchard plots at each 
stage. 
(3H)DHA binding data are summarized in Table I. Maximum DHA 
binding (Bmax) and the dissociation constant (Ka) of DHA were determined 
by non-linear regression analysis and compared at each stage of 
endotoxicosis. There were no significant differences in either parameter 
at any time during the endotoxicosis as determined by unpaired student's 
t test. Furthermore there were no differences among the control groups 
or the endotoxin groups. Specific binding averaged 63.7%+2.3% in saline 
treated hearts and 60.4%+1.9% in endotoxin treated hearts. 
Competition Binding Experiments 
Agonist binding characteristics were determined at each stage by 
performing isoproterenol-DHA competition assays. The mean values for 
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Figure 1. 
Specific binding of 3-dihydroalprenolol (DHA) to ventricular 
or endotoxin administration. Each point represents the mean .:!::. SEM of 5-6 
preparations, each from a different animal. Inset shows Scatchard plot 
of DHA binding, determined from mean values. 
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Figure 2. 
Specific binding of 3H-dihydroalprenolol (DHA) to ventricular 
membranes from control and endotoxin-treated rats 3 hours after saline 
or endotoxin administration. Each point represents the mean .:!:. SEM of 4-5 
prearations, each from a different animal. Inset shows Scatchard plot of 
DHA binding determined from mean values. 
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Figure 3. 
Specific 3H-dihydroalprenolol binding to ventricular membranes 
from control and endotoxin-treated animals at the terminal stage of 
endotoxicosis. Each point represents the mean + from 8-10 preparations, 
each from a different animal. Inset shows Scatchasrd plot for DHA 
binding determined from mean values. 
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TABLE I. 3H-DIHYDROALPRENOLOL BINDING CHARACTERISTICS 
Kd (nM) Bmax (fmol/mg) 
Stage of endotoxicosis 
Control 3.53+1.01 82.0+9.8 
0.5 HOURS 
Endotoxin 2.79+0.89 73.0+7.9 
Control 2.51+0.39 90.4+2.3 
3.0 HOURS 
Endotoxin 3-99+0.69 95.9+15.9 
Control 3.46+0.83 108.4+16.7 
TERMINAL 
Endo toxin 3.78+0.65 101.7+15.3 
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data derived from these assays is displayed in Table II. The dose of 
isoproterenol required to inhibit 50% of DHA binding (Ic50 ) was not 
significantly different between control and endotoxin groups at any 
time. 
The slope factors for each competition curve were also 
determined. This value is essentially the same as the Hill coefficient. 
It is called a pseudo-Hill coefficient because the binding of the 
agonist is indirectly assessed by virtue of its displacement of 
radiolabeled antagonist. When the binding reaction follows the 
principles of mass action the slope factor is 1.0. A slope factor 
significantly different from 1.0 implies that the ligand receptor 
reaction is more complex than simple mass action. A slope factor less 
than one is commonly the result of heterogeneity of binding sites. The 
slope factors at 0.5 and 3 hours are not significantly different and are 
less than 1.0. At the terminal stage of endotoxicosis the slope factors 
for control and endotoxic isoproterenol binding are significantly 
different. The control is significanly less than 1.0 whereas the 
endotoxin value approaches 1.0. 
Figure 4 depicts representative isoproterenol competition curves 
at the terminal stage of endotoxicosis. The curve for the control tissue 
is shallow and has a slope factor of 0.54. The curve for the endotoxic 
tissue is of normal steepness and has a slope factor close to 1.0. A 
trailing foot is noticeable at the high dose range. The data in Table 
III are the average values for isoproterenol binding at the terminal 
TABLE II. ISOPROTERENOL BINDING CHARACTERISTICS 
IC50 (-log M ISO) SLOPE 
Stage of endotoxicosis 
Control 7 .65+0 .13 o. 78+0.16 
0.5 HOURS 
Endotoxin 7 .84+0.19 0.61+0.03 
Control 7.86+0.13 0.64+0.07 
3.0 HOURS 
Endotoxin 7 .44+0.17 0.71+0.07 
Control 7 .06+0.16 0.60+0.06 
TERMINAL 
* Endo toxin 7.27+0.11 0.91+0.12 
* p<0.05 
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Figure 4. 
3H-dihydroalprenol competition curves for isoproterenol in 
ventricular membranes from control and endotoxin-treated rats at the 
terminal stage of endotoxicosis. The data points are the means of 
duplicate determinations in representative experiments. 
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TABLE III. ISOPROTERENOL BINDING PARAMETERS 
IN TERMINAL ENDOTOXICOSIS 
CONTROL ENDO TOXIN 
4.6+0.8 
1883+827 
466+211 
60.3+5.2 100 
39.7+5.2 
94 
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stages of shock as determined by computerized non-linear curve fitting 
methods (98). The curves for the control membranes are best explained by 
two affinity states of the receptor, 60% of the total receptor 
population are of high affinity (R1 ) with a dissociation constant (K1 ) 
of 4.6+0.8 nM; 40% of the receptors are of low affinity (R2 ) with a 
dissociation constant of 1883+827 nM. The ratio of the dissociation 
constants for high and low affinity states (K2/K1) was 466+211. The 
curves for the membranes from endotoxin treated animals modeled best to 
a single population of receptors with relatively low affinity (33.9+14.5 
nM) for the agonist. The existence of two heterogeneous states was no 
longer apparent at the terminal stages of endotoxicosis. 
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DISCUSSION 
Previous data from our laboratory has indicated a decrease in 
sensitivity of adenylate cyclase activation to the beta-adrenergic 
agonist, isoproterenol at the terminal stages of endotoxicosis (115). It 
was proposed that this was due to a problem at the receptor level and 
not with the enzyme, itself. The data from the present study support the 
hypothesis that the changes at terminal endotoxicosis are due to a 
coupling problem between the agonist-receptor complex and the catalytic 
unit of adenylate cyclase. 
It is currently believed that beta-adrenergic agonists promote 
the formation of a ternary complex, composed of the agonist, the 
receptor and the guanine nucleotide regulatory protein (N protein or N). 
Formation of this complex results in a high affinity state of the 
receptor. The ternary complex is transient and is destabilized by GTP. 
When the agonist-receptor complex is no longer associated with the 
guanine nucleotide regulatory protein it reverts to a low-affinity 
state. GTP binding to the alpha subunit of the N protein induces a 
conformational change such that the alpha and beta subunits dissociate 
and GDP is released. The N-GTP unit complexes with the catalytic moiety 
of adenylate cyclase, thereby activating it and initiating cAMP 
production. Cyclic AMP then mediates the events that result in enhanced 
inotropism, primarily via phosphorylation of intracellular proteins. If 
an antagonist is added to the system rather than an agonist the chain of 
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events is blocked because there is no impetus to form the crucial 
ternary complex (23,82,127). 
Competition curves for agonists in the absence of guanine 
nucleotides are shallow with slope factors less than 1.0. Computer 
analysis of these curves reveals that the receptor exists in two 
affinity states, one high and one low. The high affintiy state 
presumably reflects receptors that are complexed with agonist and N 
protein while the low affinity state reflects receptor-agonist complexes 
that have dissociated from N. If high concentrations of guanine 
nucleotides are added the competition curve steepens and the slope 
factor approaches 1. Analysis shows all the receptors to be in a low 
affinity state as a result of destabilization of the ternary complex. 
Competition curves for antagonists are also steep with slope factors of 
1.0, which reflects the inability of antagonists to induce the formation 
of a ternary complex. All of the receptors appear to be in a low 
affinity state (65). 
The phenomenon of tachyphylaxis or desensitization has been 
recognized for many years and denotes a state of diminished 
responsiveness to an agonist, drug or hormone after prior exposure to 
the substance (127). Rats receiving doses of endotoxin comparable to 
those used in this study have exhibited very high levels of sympathetic 
nerve activity and plasma catecholamines (63). The concentrations of 
catecholamines in the vicinity of the receptors may approach those 
necessary to initiate desensitization within the time course of the 
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endotoxicosis. Agonist-induced desensitization has been shown to be both 
time and concentration dependent in vitro (96). The characteristics of 
desensitization in vivo have not been defined as well although similar 
mechanisms may be involved. It is certainly possible that the receptor 
changes seen in this study may be due to catecholamine-induced 
desensitization. 
The phenomena of receptor-cyclase uncoupling and receptor down 
regulation are thought to be the mechanisms responsible for the 
desensitization observed after chronic exposure to agonist. In the 
present experiments we examined the possibility that either or both 
mechanisms occur during endooxicosis. DHA binding parameters, Kd and 
Bmax, do not change at any stage of endotoxicosis. This suggests that 
there are no gross structural changes in the receptor resulting from the 
endotoxicosis. Recent studies (46,125,130) have shown that after 
exposure to agonists beta-adrenergic receptors are internalized in some 
tissues. These receptors may be recovered in light vesicles which are 
sedimented during centrifugation. The vesicles sediment at 
centrifigation forces that vary with the particular tissue (43). Thus if 
receptors are measured only in the particulate fraction of desensitized 
tissue, it would appear that receptors were lost, when in fact they were 
in vesicles. It appears that no other component of the receptor-cyclase 
system is sequestered with receptor and thus the receptors are not 
functional when vesicularized (125,134), but they maintain their 
integrity (128). Vesicular receptors bind lipophilic antagonists with 
the same affinity as native receptors since antagonist binding is 
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independent of N protein interactions (47). 
Recently, Limas and Limas (80) have described beta-receptor 
internalization in rat myocardial membranes after prolonged exposure to 
isoproternol. The "lost" receptors were recovered in the cytosolic 
fraction. The apparent lack of change in receptor number in the 
endotoxic tissue in the present study suggests that either all the 
receptors are present at the membrane surface, with no down regulation, 
or that internalized receptors as well as surface receptors are being 
identified. We have yet to determine if cytosolic receptors are 
sedimented under the conditions of the assay as performed in the present 
study. Harden (43) has presented a model for the cellular processing of 
beta-adrenergic receptors during catecholamine-specific desensitization 
that differentiates between internalized but detectable receptors and 
receptors that are lost due to degradation or modification. It is 
apparent that there is no loss of total receptors in the endotoxic 
tissues. 
Early in the experimental period endotoxin or the mediators of 
endotoxicosis do not appear to affect agonist binding to receptors as 
determined by agonist competition curves. Computer analysis showed no 
difference in slope factors or rc50 • At the terminal stage of 
endotoxicosis there is no difference in rc50 , but there is clearly a 
difference in slope factors between the control and endotoxic group 
(0.60+0.06 vs. 0.91+0.12). When computer analyzed, the curves from 
control membranes model to a two state fit, one high-affinity state and 
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one low affinity state, which corresponds well to the current theory. 
The curves from terminal endotoxic ventricular membranes model to a one 
state fit, the affinity of the receptor being somewhat less than the 
high affinity state of the control but considerably greater than the low 
affinity state. The total loss of the low affinity site is somewhat 
puzzling. The slope factor, near one, suggests one homogeneous site, yet 
it might be expected from data analyzed in other desensitized tissues 
that there would still be two state binding. The high affinity site of 
frog erythrocytes has been shown to decrease significantly in affinity 
and number after exposure to agonist, whereas the low affinity site has 
smaller changes in absolute number and affinty under the same conditions 
(65). One possible explanation of the present data is that the number of 
low affinity sites decreases to a such a degree that the computer 
analysis is not capable of resolving the binding into two states (24). 
Another possibility is that there is an alteration in dissociation of 
the ternary complex such that the formation of the low affinity state is 
modified. This could occur if GTP binding to the N-protein is 
compromised. Alternatively, some of the receptors from the endotoxic 
membrane may be in light vesicles. These receptors have been reported to 
exhibit only low affinity binding for isoproterenol that is not affected 
by GTP (44). 
The lack of change in the rc50 for isoproterenol may be due to 
the fact that almost half of the receptors in the control membranes are 
in a very low affinity state and all (or the majority) of the receptors 
in the endotoxic membranes have an affinty between the high and low 
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affinty states of the control membranes. Alternatively, any differences 
in IC50 may be masked by the variability of the 3H-DHA concentration 
used in the competition assays (135). Regardless of this apparent 
discrepancy, the shift to a lower affinity state in the endotoxic 
membrane suggests some alteration in the ability of the receptor-agonist 
complex to associate or couple with the N protein. This decrease in 
receptor affinity for isoproterenol would then appear to account for the 
rightward shift in the adenylate cyclase dose response curve (115) in 
ventricular membranes from terminal endotoxic rats. 
Decreases in membrane fluidity have been implicated as being 
responsible for problems with receptor-cyclase coupling. Mallorga et al 
(89) have noted increased phosphatidylcholine degradation in rat C6 
astrocytoma cells exposed to isoproterenol for 2 hours, which was 
associated with increased phospholipase A activity. Treatment of rats 
with quinacrine, a 
desesensitization of 
immobilization stress 
phospholipase A inhibitor, prevented 
cardiac beta-adrenergic receptors due to 
or isoproterenol administration (131). Liu and 
colleagues have reported increased phospholipase A activity in heart 
homogenates from dogs treated with endotoxin for three hours (84). More 
recently they have observed an endotoxin-induced decrease in canine 
myocardial phospholipid methylation as assessed by methyltransferase 
activity (87). They suggest that these changes modify the myocardial 
membrane-lipid profile such that fluidity is decreased. An increase in 
the viscosity of the membrane in the area of the receptor may inhibit 
lateral movement in the membrane. This in turn can compromise coupling 
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of the receptor with the guanine nucleotide regulatory protein and 
adenylate cyclase. 
In avian erythrocytes and certain cultured cell lines the 
evidence suggests that a change in receptor structure may be responsible 
for decreased coupling of desensitization. Stadel et al (124) have shown 
that catecholamine-induced desensitization of adenylate cyclase in 
turkey erythrocytes correlates with stable modification of the 
beta-adrenergic 
phosphorylation 
phosphorylation 
receptor and is associated with agonist-promoted 
of beta-receptor peptides. Additionally, the 
may be cAMP mediated (123). Bobik and Little (9) have 
presented data from chick-heart studies that is compatible with the 
hypothesis that beta-adrenoceptor desensitzation could be due 
cAMP-dependent phosphorylation of the receptor. They found that 
incubation of cultured chick embryo ventricular cells with 
phosphodiesterase inhibitors attenuated isoproterenol-stimulation of 
CAMP production. Desensitization in rat heart may also be due to 
phosphorylation since it was prevented by cordycepin, a nonspecific 
phosphorylation inhibitor (81). Sympathetic nerve activity in the rat 
increases early in endotoxicosis and is maintained at elevated levels 
for at least 6 hours (63). The cAMP generated in response to adrenergic 
stimulation of beta-receptors early in endotoxicosis may be influential 
in initiating the desensitization process in rat myocardial membranes. 
It is not known whether the alterations in receptors and the 
decreased sensitivity of adenylate cyclase to adrenergic stimulation 
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(115) that occur during endotoxicosis are due 1) directly to the 
endotoxin, 2) to a mediator produced in endotoxicosis or, 3) to elevated 
sympathoadrenal activity. The direct effects of endotoxin on in vitro 
canine hepatic membrane preparations (32,85) may not be present in 
myocardial tissue, which is much different from hepatic tissue in 
structure, function and metabolism. Preliminary experiments designed to 
protect beta-adrenergic receptors from excessive stimulation during 
lethal endotoxicosis, have been fruitless to this time. Administration 
of atenolol, a cardioselective beta-receptor antagonist, along with 
endotoxin exacerbates the effects of endotoxin and the time to death is 
reduced (unpublished observations). This data does not answer any 
questions about the role of catecholamines in the myocardial 
desensitization but it does stress the importance of sympathetic 
activity for support of the myocardium during endotoxicosis. Future 
experiments should concentrate on the stimulus for desensitization in 
the endotoxic myocardium and the underlying mechanisms. 
The alterations in the myocardial beta-adrenergic receptor 
during endotoxicosis appear modest, but the significance of these 
changes is considerable. During sepsis or endotoxicosis the myocardium 
is undergoing a progressive deterioration (58). Initially, sympathetic 
nervous system activity augments and supports myocardial performance. 
This becomes increasingly important as myocardial function degenerates. 
However, the myocardial response to adrenergic stimulation is also 
deteriorating (1,6,107) and at the same time myocardial sympathetic 
nerve endings are becoming depleted of norepinephrine (104). Thus the 
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homeostatic mechanisms that were supporting cardiovascular function are 
exhausted and the conditions are set for circulatory collapse. 
CHAPTER VI 
INTEGRATED DISCUSSION 
Sympathoadrenal-myocardial effector mechanisms important during 
endotoxicosis were studied in the three projects of this dissertation. 
The primary goal of these studies was to characterize the cellular 
mechanisms involved in the myocardial response to catecholamines in the 
endotoxic state as compared to normal. 
The first project examined cAMP levels in the rat ventricle in 
situ during a 6 hour period of endotoxicosis. It was found that cAMP 
tissue levels were depressed early in endotoxicosis, return to normal at 
the intermediate stages, and were again depressed at the terminal stages 
of endotoxicosis. These in situ levels of cAMP are probably not basal 
levels since plasma concentrations of catecholamines rise dramatically 
during decapitation (26). Stimulation of ventricular cAMP production in 
vitro by isoproterenol was normal in the heart in the early stages of 
endotoxicosis but was attenuated by 3 hours into the experimental 
period. 
buff er 
It is 
Basal levels of cAMP content after a 30 minute incubation in 
medium were not different at any time during the endotoxicosis. 
concluded that the early decrease in cAMP content in the in situ 
endotoxic ventricle is not due to alterations in production of cAMP, but 
rather due to increased degradation, possibly by insulin stimulation of 
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phosphodiesterase. Late decreases in cAMP content are most likely due to 
a shortage of available substrate and/or a decrease in the ability to 
stimulate production via beta-receptor mechanisms. 
Since alterations in cAMP production may have been associated 
with the changes in the enzyme system responsible for generation, the 
second project focused on myocardial adenylate cyclase activation during 
endotoxicosis. Stimulation of adenylate cyclase activity by NaF or 
GppNHp was not different in ventricular membranes from endotoxic rats as 
compared to controls at any time during the experimental period. These 
agents stimulate catalytic activty via the guanine nucleotide regulatory 
protein and bypass the receptor. When the beta-adrenergic receptor 
agonist, isoproterenol, was used to stimulate adenylate cyclase activity 
there was no difference between control and endotoxic preparations at 
0.5 or 3 hours. At the agonal stage, myocardial adenylate cyclase in the 
endotoxic membranes was 3 times less sensitive to isoproterenol 
stimulation than control membranes and had a decreased maximum response. 
It is concluded from this data that the guanine nucleotide regulatory 
protein, the catalytic unit of adenylate cyclase, and their interaction 
are not altered during endotoxicosis, but that receptor-mediated 
mechanisms are modified. 
The third project assessed beta-adrenergic receptor 
characteristics during the endotoxic episode. Antagonist binding with 
DHA did not uncover any differences between control or endotoxic 
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ventricular membrane beta receptors at any time after endotoxin 
administration. Neither the affinity constant nor density of receptors 
was affected by endotoxicosis. Analysis of agonist binding to receptors, 
as determined from isoproterenol competition curves, indicated that 
there was a decreased ability of the agonist to promote the high 
affinity state of the receptor in the endotoxic membrane in the terminal 
stages. Formation of the ternary complex is an essential intermediate 
for coupling of the receptor with adenylate cyclase (23,82). It is 
concluded that there is no "down regulation" of receptors during 
endotoxicosis, however there is a decrease in receptor coupling to the 
adenylate cyclase. This uncoupling is responsible for attenuated 
isoproterenol-stimulation of adenylate cyclase. 
These experimental findings are interpreted as evidence that the 
modifications of receptor mechanisms in the endotoxic rat ventricle are 
due to agonist induced desensitization. Sympathetic nerve activity to 
the heart and circulating plasma catecholamines are known to be greatly 
increased during endotoxicosis (63,105). Furthermore, rats infused with 
catecholamines for equivalent periods develop receptor changes similar 
to those observed in the present study (18). Such hearts developed a 
decreased functional response to endogenous catecholamines without 
decreases in receptor number. 
It is difficult to substantiate the theory of desensitization in 
the endotoxic rat. Infusion of exogenous catecholamines in vivo to 
---
stimulate cardiac receptors is problematic. First of all, reflex 
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mechanisms may be stimulated that alter endogenous catecholamine and 
acetylcholine release. Increased catecholamine release as a response to 
vasodilation would cause an overestimation of the sensitvity to the 
infused drug, since the stimulation from two sources would summate. 
Withdrawal of sympathetic activity during vasoconstriction would cause 
an underestimation of sensitivity since tonic release is depressed. 
Acetylcholine, that is also released when blood pressure increases, can 
antagonize catecholamine stimulated mechanisms and would thereby cause a 
decreased sensitivity to the exogenous beta-adrenergic agonist. 
Secondly, the effects of an infusion of agonist may be masked by plasma 
levels of catecholamines that are already exaggerated in the endotoxic 
state. Protection of cardiac beta receptors to prevent overstimulation 
is also difficult. Sympathectomy and adrenal demedullation (70), 
ganglionic blockade (unpublished observations) or beta receptor blockade 
(13) sensitize rats to endotoxin lethality, such that the animals die 
within minutes of administration. It may be possible to partially block 
receptors with low doses of antagonists and/or administer the antagonist 
after the initial hypotension is corrected. However, even apparently 
minor pertubations may compromise sympathetic support necessary for 
adequate myocardial performance. The use of isolated hearts or tissues 
from endotoxin-treated animals is an attractive alternative, however 
removal from the endotoxic environment may be ambiguous since other 
factors may be acting on the heart in situ. 
Further evidence in support of the desensitizaton phenomenon is 
that the myocardial beta receptors in terminal endotoxicosis exhibit 
characteristics 
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similar to both homologous and heterologous beta 
receptor desensitization. Homologous desensitization is defined as as 
specific loss of catecholamine stimulated adenylate cyclase activity and 
demonstrates both the uncoupling and receptor loss phenomena. 
Alterations in receptors comprise the major lesions in such cases. In 
contrast, heterologous desensitization is characterized by a loss in 
sensitivity to F"" and GppNHpp as well as a decreased responsiveness to 
catecholamines, but no loss of receptors (127). These definitions are 
reflective of data acquired from a cultured cell lines and erythrocytes, 
however the mechanisms of myocardial desensitization have not been as 
well characterized. Desensitized beta receptors in the present study 
show a loss of catecholamine stimulated activity and no loss of F"" or 
GppNHp stimulated activity which is similar to homologous desentization 
mechanisms, however there is no loss of receptors as with heterologous 
desensitization. However the time course of the endotoxicosis may not 
have been long enough for receptor down-regulation to develop. 
The myocardial beta-receptor changes and the subsequent decrease 
in responsiveness to catecholamines are not the initiating factors in 
the myocardial dysfunction of endotoxicosis, but such changes may 
contribute to the pathphysiology of circulatory shock. Therefore, the 
following schema of events, leading to myocardial failure in shock, is 
proposed: endotoxin or the septic insult initiates the release of 
various hormones and mediators. An initial hypotension develops due to 
the direct effects of endotoxin, a mediator, or histamine or a 
combination of all three. Sympathetic mechanisms are activated 
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neurogenically, by endotoxin directly, or by a mediator. The hypotension 
is compensated and sympathetic activity remains elevated, possibly to 
excess, to maintain blood pressure and for general support of an 
organism under stress. The signal that stimulates sympathetic activation 
after the hypotensive phase is not clear. Myocardial dysfunction is 
perpetuated directly or indirectly by mediators of endotoxicosis. 
Factors contributing to the myocardial depression are decreases in 
contractile protein activation, calcium dyshomeostasis, decrease in 
energy substrate availablity, and electrophysiological changes. As heart 
function continues to decline sympathetic support is increasingly 
important and sympathoadrenal activity is increased accordingly. The 
catecholamines initially serve a protective role, but eventually 
concentrations of catecholamines at the receptor also reach supranormal 
levels. Exposure of the receptors to these concentrations for a 
prolonged period then desensitizes the receptor. Therefore, the failing 
heart is not supported as well and myocardial performance is no longer 
sufficient to meet the cardiovascular requirements of an organism that 
is also metabolically and immunologically stressed. Death follows as a 
result of cardiovascular, metabolic, and immunologic collapse. 
It important to note that sympathetic activation in the 
endotoxic rat is grossly exaggerated in comparison to activation in 
other stress states (26,27,111). The stimulus that is responsible for 
the hyperactivation is ultimately responsible for the transiton of 
beneficial to detrimental effects of adrenergic stimulation on the 
heart. By some unknown mechanism the myocardial membrane recognizes that 
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the adrenergic stimulation is greater than necessary and in order to 
decrease activation of intracellular processes the receptors are 
desensitized. Unfortunately, myocardial contractility is decreased 
during endotoxicosis and the loss of receptor activation compromises 
contractility further. It is probable that myocardial performance could 
be supported more adequately if plasma catecholamines did not reach such 
exaggerated levels. In agreement with this concept, rats or patients 
that had relatively smaller increases in plasma catecholamines appear to 
be more able to survive an endotoxic or septic insult (4,63). 
In the case of the rats it appears that the lower levels of 
catecholamines correlate with an increased time to death but most 
animals eventually die (63). This suggests that it may take longer for 
desensitization and myocardial dysfunction to occur in the endotoxic 
animals with lower concentrations of plasma catecholamines and/or that 
mechanisms other than cardiovascular collapse are responsible for the 
death of the animal. Relevant to human sepsis it would appear that 
protection of beta-adrenergic receptors with antagonists, while 
stimulating contractility with non-adrenergic agents and supporting 
metabolic mechanisms could be beneficial to survival. 
Further investigation of beta-adrenergic mechanisms in 
endotoxicosis should aim at determining the role catecholamines or other 
mediators have in causing the receptor changes observed in the present 
study and for methods to protect the beta-adrenergic mechanisms. 
Desensitization of myocardial adenylate cyclase may be non-specific in 
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that all normal activators show losses similar to catecholamines. 
Therefore, it would also be important to determine whether other 
substances that stimulate myocardial adenylate cyclase, such as glucagon 
or histamine, become less effective and the mechanisms involved. 
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APPENDIX A 
METHODS IN DETAIL 
A. Animals 
Healthy male Holtzman rats (derived from the Sprague-Dawley 
strain) of 300-400 grams body weight were used in all experiments. Rats 
were chosen for the studies due to the ease of handling and the 
extensive data base regarding the patho-physiology of sepsis. Upon 
receipt from the supplier (Holtzman Company, Madison, Wisconsin), 
animals were maintained in the Animal Research Facility (Stritch School 
of Medicine) for at least one week prior to experimentation. This period 
allowed the animals to recover from the stress of shipping and adjust to 
the 12 hour light-dark cycle (light from 0700 to 1900 hours) and other 
environmental conditions. Rats were housed three or four per cage (cage 
dimensions: 16" length, 9.5 11 width, and 7" depth). Ambient temperature 
was approximately 22°c and the humidity was 30%-50%. Animals were 
maintained on Wayne Lab Blox and tap water ad libitum. Rats had free 
access to food at all times prior to experiments. 
B. Model of Sepsis 
The endotoxin model of a gram-negative septic insult was 
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employed in all experiments. Salmonella enteritidis endotoxin, 
lipopolysaccharide B, prepared by the Boivin method (trichloroacetic 
acid extraction) was purchased from Difeo Laboratories, Detroit, 
Michigan. The same batch (#703252) of endotoxin was used in all 
experiments. Endotoxin was prepared daily in 0.9% saline at a 
concentration of 5 mg/ml. Rats were lightly anesthetized with ether 
(Mallinkrodt) and received 16.7 mg/kg endotoxin intravenously via the 
dorsal vein of the penis. Tihs dose of endotoxin produced 80-90% 
lethality in 24 hours, in agreement with previous studies (). Control 
animals received a comparable volume of saline. All experiments were 
initiated between 0700 and 0930 hours to reduce the influence of any 
diurnal factors such as plasma corticosteroid concentration (). After 
administration of endotoxin or saline animals were placed in a shoe box 
cage (4/cage) and followed for a predetermined time or until a shock 
syndrome ensued. Water was available ad libitum. The terminal stage of 
shock was considered to be that time when the animal lost its righting 
reflex. 
C. Ventricular slice preparation 
To determine the ability of a beta-adrenergic receptor agonist 
to stimulate cyclic adenosine-3',5'-monophosphate (cAMP) production in 
the endotoxic rat heart, in the absence of other mediators, a 
ventricular slice preparation was employed. 
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Rats were decapitated at 0.5 and 3.0 hours after endotoxin or 
saline administration or when they lost their righting reflex. Saline 
treated animals were sacrificed at a time comparable to those animals 
that were in shock. Times were chosen based on initial experiments that 
observered the time course of endotoxicosis. Hearts were rapidly removed 
and placed in 4°c Krebs-Ringer-Bicarbonate buffer (KRB) which contained 
NaCl, 118.5 mM; KCl, 4.8 mM; KH2po4 , 1.2 mM; Mgso4 , 1.2 mM; CaC12 , 3.6 
mM; glucose, 5.5 mM; and NaHco3 , 23.8 mM. The KRB was previously gassed 
for 30 min with 95%02-5%Co2 and the pH adjusted to 7.4 with HCl or NaOH. 
The atria, large vessels and adipose tissue were trimmed and the 
ventricles sliced in half transversely such that each half contained 
both right and left ventricle. The ventricles were sliced in a cold room 
with a Stadie-Riggs microtome (A. Thomas and Co.). Slices were 
approximately 0.5 mm thick. The slices were randomly placed in six 10 ml 
beakers that contained 2.4 ml of oxygenated KRB, 37°c, pH 7.4. Each 
beaker contained 3-4 slices of ventricle with a total weight of 75-100 
mg. The slices were incubated for 15 min in a Dubnoff metabolic shaker 
while being continuously gassed with 95%02-5%Co2 , to recover from the 
previous manipulations and reach an basal state. After the incubation 
period, 100 ul of 2.5x10-5M isoproterenol (final concentration of 
10-6M), prepared in 0.1% ascorbic acid to prevent oxidation of the 
catecholamine, was added to 2 beakers. Two other beakers received 100 ul 
of 0.1% ascorbic acid and the last two received 100 ul of KRB. 
Forty-five seconds after the additions were made the slices were removed 
from the beakers, blotted dry, and frozen with brass clamps previously 
cooled in liquid nitrogen. The samples were stored at -195°C, in liquid 
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nitrogen, until assayed for cAMP. 
Preliminary experiments tested various doses of isoproterenol 
and times of exposure to the drug. The dose used (10-6M) was found to 
stimulate cAMP production maximally and the time (45 sec) was sufficient 
to develop this response. 
D. Implantation of Cannulae 
In order to collect blood samples throughout the time course of 
endotoxicosis a group of rats were instrumented as follows. Rats were 
anesthetized with 4% halothane in oxygen for induction and maintained on 
1.75% halothane in oxygen. A 2 cm long incision was made just lateral to 
the ventral midline on the left side of the neck. The sternohyoid and 
sternomastoid muscles were reflected and the left common carotid artery 
exposed. A cannula fashioned from PE-50 polyethylene tubing (Clay-Adams) 
was inserted into the carotid artery until the tip entered the 
descending aorta (this was vwerified at autopsy). The cannula was 
exteriorized in the mid-scapular region and the incision was closed with 
surgical staples. These animals were allowed to recover approximately 30 
minutes before the experimental procedure was initiated • At that time 
they were treated exactly as the non-cannulated animals (see Section B), 
except that they were placed one per cage in order to eliminate tangling 
and chewing of cannulae. Cannulae were filled with heparinized saline 
(100 U/ml). 
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Blood samples of 0.8 ml were taken from the carotid cannula at 
predetermined times and replaced by a similar volume of saline. Samples 
were placed in 1.5 ml microcentifuge tubes containing 16 ul of a 
solution containing 90 mg/ml ethyleneglycol-bis-(B-amino-ethyl ether) 
N,N'-tetraacetic acid (EGTA) and 60 mg/ml glutathione (pH 6-7). The 
tubes were held on ice until centrifuged at approximately 10,000 g in a 
Eppendorf Model 5414 microfuge. The plasma was stored at -40°C, in a 
Revco freezer, until assayed for catecholamines. 
E. Plasma Catecholamine Determination 
Concentrations of circulating plasma epinephrine and 
norepinephrine were assayed according to the method of Passon and Peuler 
(1) as modified by Peuler and Johnson (2) by use of a kit supplied by 
The Upjohn Company, Kalamazoo, Michigan. This is a single isotope 
radioenzymatic method that simultaneously measures epinephrine and 
norepinephrine in plasma samples of 50 ul or less with a sensitivity of 
1 pg (20 pg/ml plasma). This technique is based on the use of the 
isolated enzyme catecholamine-0-methyltransferase (COMT) to transfer a 
radioactive methyl group from S-adenosyl-L-methionine (SAM) to an 
endogenous catecholamine acceptor molecule to form a 0-methyl 
catecholamine 
3H-normetanephrine 
derivative. Norepinephrine is converted to 
in the presence of SAM(3H-methyl) and epinephrine is 
converted to 3H-metanephrine. 
Fifty ul aliquots of plasma were added to incubates containing 
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100 mM Tris, 30 mM MgC12 , 10 mM EGTA, 10 ul of COMT solution, 1 mM 
reduced glutathione, 0.1 mM benzylhydroxyamine (to inhibit dopa 
decarboxylase), 5 uCi SAM(3H-methyl, 4.3-5.5 mM). Total volume was 100 
ul and pH was approximately 8.1-8.3. One hundred picograms of 
norepinephrine and epinephrine were added to duplicate incubation 
mixtures, also containing 50 ul of sample plasma, as internal standards. 
Reagent blanks contained the incubation mixture, however 50 ul of 
vehicle, containing EGTA and glutathione, were substituted for the 
plasma. 
The samples were incubated in a shaking water bath at 37°C for 
60 minutes. The reaction was stopped by the addition of 50 ul of a 
solution containing 800 mM boric acid, 80 mM ethylenediamine tetraacetic 
acid-disodium salt (EDTA-Na2 ), and 4 mM each of metanephrine and 
normetanephrine in 1N NaOH. The resulting solution (pH 10.0) was mixed 
vigorously for 15 s with 2 ml of toluene-amyl alcohol (3:2, v:v). The 
3H-methoxycatecholamine derivatives are much more soluble in the organic 
mixture than in the aqueous reaction mixture. The tubes were centrifuged 
at 800 g for two minutes in an International Equipment Company (IEC) 
Model UV centrifuge to separate the organic and aqueous phases. The 
aqueous phase was rapidly frozen in an ethanol/dry ice bath and the 
organic phase decanted into a tube containing 100 ul Of 0.1 M acetic 
acid. The 3H-methylcatecholamine derivatives were partitioned into the 
aqueous phase by mixing for 15 s. The decrease in pH effected by the 
addition of acetic acid greatly reduced the solubility of the 
derivatives in the organic phase. The tubes were centrifuged at 800 g 
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for 2 min, the aqueous phase was quick-frozen and the organic phase was 
discarded. The acetic acid phase was thawed and to it was added 1 ml of 
the toluene-isoamyl alcohol mixture. After centrifugation and freezing 
the organic phase was again discarded. One hundred ul of ethanol was 
then added to the thawed acetic acid extract and the solution was 
applied to a silica gel thin layer (Uniplate, Analtech) by use of 250 ul 
Hamilton syringes and a thin layer chromatography (TLC) Multispotter 
(Analytical Instrumentation Specialties) capable of applying 14 samples 
simultaneously. The plates were developed for 30-40 min in a solution of 
t-amyl alcohol/toluene/40% methylamine solution, 12:4:5. The plates were 
dried thoroughly using a hot air blow-dryer and two zones were 
visualized under 254 nm UV light. The upper zone contained metanephrine 
and the lower zone contained normetanephrine. Each zone was then scraped 
from the plate into a correspondingly numbered scintillation vial. The 
assay was generally interrupted at this point and the vials stored at 
4°c overnight. The procedure was completed the following morning. 
The assays for norepinephrine and epinephrine were identical. 
One ml of 0.05 M ammonium hydroxide was added to each vial to elute the 
derivatives from the silica gel. The 3H-catecholamine derivative was 
then oxidized to 3H-vanillin by the addition of 50 ul of sodium 
periodate followed 5 min later by the addition of 50 ul glycerol (10%, 
v:v). The solution was acidified by the addition of 1 ml of 0.1 M acetic 
acid and vigorous mixing. Ten ml of toluene/Liquiflor (1000:50) was 
added to each vial and the 3H-vanillin was partitioned into the organic 
phase with 30 s of shaking. Liquiflor (New England Nuclear) is a 
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PPO-POPOP toluene concentrate. 
All scintillation vials were dark adapted and then counted for 
radioactivity for 10 min in an Isocap/300 scintilation counter 
(Searle-Analytical) without quench correction. 
Calculation of Sample Catecholamine Content 
The calculations for each catecholamine are exactly the same and 
proceed as follows: 
1. The counts per minute (CPM) for each set of duplicates is 
averaged. 
2. The CPM that are due to the addition of standard are 
3. 
determined and averaged so that one value is used for all 
subsequent calculations. 
The CPM for the blank is subtracted from the CPM of each 
sample and this value is divided by the CPM due to the 
addition of standard. Thus a ratio of CPM of unknown 
catecholamine concentration to CPM of known catecholamine 
concentration is calculated. 
4. The ratio of unknown to known is multiplied by the 
concentration of standard in the assay and thus the sample 
concentration is determined. The final value is expressed as 
picograms of catecholamine/ml of plasma. 
F. Determination of Tissue Catecholamine Concentrations 
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Tissue Acquisition 
Rats were decapitated and the thorax and abdomen opened. The 
heart was excised and the ventricles separated from the atria and large 
vessels. The ventricles were blotted free of blood and frozen between 
brass clamps that were pre-cooled in liquid nitrogen. The tissue was 
then immersed in liquid nitrogen to facilitate the freezing process. The 
spleen was similarly excised and frozen. The adrenal glands were frozen 
as a pair. All tissues were stored at -195°c until assayed for 
catecholamines. 
Catecholamine Extraction 
The extraction and purification procedure is based on the 
methods of Shaw (3) as modified by Lund (4). Tissues were weighed frozen 
on a Roller-Smith balance and placed in 10 ml of ice-cold 10% 
trichloroacetic acid (TCA). Each thawed sample was homogenized for 20 s 
at a setting of 6 with a Brinkmann polytron. The homogenates were 
centrifuged for 20 min~ in an IEC centrifuge Model UV at full speed. The 
supernatant was decanted into a clean tube and the precipitate 
discarded. The supernatant was stored at 4°c until purification. 
Five ml of the sample were pipetted into a 50 ml Erlenmeyer 
flask to which had previously been added 0.5 ml of cold 0.2 M EDTA, 10 
ml of cold 0.2 M sodium acetate (NaOAc) and 1 drop of 1% 
phenolphthalein. The sample was titrated with cold 0.5 N NaOH until it 
turned slightly pink (pH 8.4). The titrated sample was added to a column 
which contained a slurry of 0.5 g acid-washed alumina. The custom-made 
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glass columns were 15 cm long with an inside diameter of 0.5 cm and a 50 
ml reservoir. After the sample ran through the column (the eluate was 
discarded) the alumina was washed with 10 ml of cold distilled water and 
the water discarded. Excess water was removed from the column tip and 5 
ml of 0.2 M acetic acid was added to the column. The resulting eluate 
was collected for analysis and was stored for up to two weeks at 4°c. In 
theory, the negatively charged catecholamines at pH a.4 adsorb to the 
positively charged alumina and after washing can be eluted with acid. 
Recovery of catecholamines is routinely 80% using this method (). 
Catecholamine Analysis 
The analysis of catecholamines is the basic method of Crout (5) 
as adapted to the autoanalyzer by Jellinek (6). The series of reactions 
are as follows. The samples are mixed with 1 M sodium acetate buffer (pH 
6.5 or 3.5) to make slightly acidic. The 2-iodo derivative of the 
catecholamine is formed when oxidized with 0.1 N iodine. The 
introduction of alkali, in the form of 1 N NaOH, causes the aminochromes 
to undergo spontaneous tautomerization to highly fluorescent derivatives 
of 3,5,6-trihydroxyindole. Ascorbic acid (7.5 mM) is added as a reducing 
agent to remove dissolved oxygen and stabilize these compounds which are 
unstable in alkaline solution. 
The relative fluorescence of these compounds was then measured 
with a Turner fluorometer which was equipped with a flow cell, a primary 
filter of the narrow pass variety at 436 nm and a secondary sharp cutoff 
filter above 510 nm. The fluorometer was also interfaced with a Beckman 
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strip chart recorder. 
The differential quantitation of epinephrine and norepinephrine 
in the same sample is possible because the degree of oxidation to the 
corresponding aminochrome by these substances varies with the pH. At a 
pH of 6.5 both norepinephrine and epinephrine are oxidized, however at a 
pH of 3.5 only the epinephrine is significantly oxidized. 
In addition to analysis at pH 6.5 and 3.5 each sample was also 
analyzed at a pH of 6.5 with 50 ng/ml norepinephrine added to the buffer 
and at pH 6.5 with the ascorbate step delayed. The first modification 
allows for the estimation of fluorescent quench. The second modification 
produces a blank since the 3,5,6-trihydroxyindole is destroyed before 
the fluorescence can be determined. 
Calculation of Tissue Catecholamine Content 
The concentrations of norepinephrine and epinephrine in each 
sample eluate are estimated differentially by solving the following 
simultaneous equations: 
(a/b) x NE + (c/d)" x E = peak height of sample at pH 6.5 
(e/b) x NE + (f/d) x E = peak height of sample at pH 3.5 
where: 
a = peak height of norepinephrine standard at pH 6.5; 
b = concentration of norepinephrine standard; 
c = peak height of epinephrine standard at pH 6.5; 
d = concentration of epinephrine standard; 
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e = peak height of norepinephrine standard at pH 3.5; 
f = peak height of epinephrine standard at ph 3.5 
NE = concentration of norepinephrine in sample; 
E = concentration of epinephrine in sample; 
Solving the equations gives a value of ug of catecholamine/ml of 
eluate. To determine tissue concentration this value is multiplied by 
the total eluate volume (10 ml + tissue wt. in ml) and divided by the 
weight of the sample. The final value is expressed as ug of 
catecholamine/g of tissue wet wt. 
In practice, all data reduction and calculations were performed 
using a computer program written by Benet J. Pardini, Ph.D, which was 
converted to Applesoft basic by the author. 
G. Cyclic AMP determination 
All procedures are based on the radioimmunoassay as developed by 
Steiner (7). The reagents and radioisotope were supplied in kit form by 
New England Nuclear (Boston, MA). 
The basic principle of the radioimmunoassay (RIA) is the 
competition between radioactive and non-radioactive antigen for a fixed 
number of antibody binding sites. As increasing amounts of 
non-radioactive antigen (e.g. standards or unknowns) and a fixed amount 
of radioactive antigen are allowed to react with a constant amount of 
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antibody, a decreasing amount of the labelled antigen is bound to the 
antibody. This relationship can be expressed as a standard curve and the 
amount of unlabeled antigen in a sample is measured by interpolation 
from this curve. 
Preparation of Tissues 
Frozen ventricular slices were placed in 2 ml of ice-cold TCA 
and whole ventricles were placed in 10 ml. All tissues were weighed on 
Roller-Smith balance prior to homogenization. Tissues were homogenized 
at 4°c for 20 s with a Brinkmann polytron at a setting of 6. The 
homogenates were centrifuged in a IEC Model UV centrifuge at 1800 g. The 
supernatatants were decanted and stored at -40°C until purification. 
The TCA supernatants were thawed and 1 ml was placed in a 10 ml 
conical centrifuge tube. The supernatants were extracted four times with 
4 ml of ethyl ether saturated with water. The extracted aqueous phase 
was then frozen and lyophilized. The residue was dissolved in 1 ml of 50 
mM sodium acetate buffer, pH 6.2, and used directly in the immunoassay. 
Cyclic AMP Assay 
Reagents were prepared daily to the appropriate specifications. 
The cAMP standard was reconstituted such that the resulting solution 
contained 5000 picomoles/ml in 50 mM sodium acetate buffer, pH 6.2. A 
standard curve was prepared from this solution such that the final 
amounts of cAMP in the assay tubes were 25.0, 10.0, 5.0, 2.5, 1.0, 0.5, 
0.25, 0.1 and 0 picomoles. The lyophilized antiserum complex which 
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contained rabbit cAMP antibody pre-reacted with sheep anti-rabbit 
globulin, was reconstituted in distilled water resulting in a solution 
of 0.1 M sodium phosphate buffer (pH 6.2) containing suffficient 
antibody to bind 40-50% of the labeled antigen in the absence of 
unlabeled antigen. The labeled cAMP is a tyrosine methyl ester 
derivative of 2'-0-succinyl-cAMP (ScAMP-TME), iodinated on the tyrosine 
moiety. Steiner et al (7) reported that cyclic nucleotides substituted 
at the 2'-0-position have higher affinity for antibody than 
unsubstituted cyclic nucleotide. 
A 100 ul 
ScAMP-TME-(1 25r), 
aliquot of standard or sample was added to 100 ul of 
7x1o-3 uCi (sp. act. 3000 uCi/ug), and 100 ul of 
antiserum in a 12x75 mm glass culture tube, at room temperature. All 
samples were assayed in duplicate. The mixture was vortexed, covered 
with aluminum foil, and allowed to incubate at 4°c for 16-18 hours. In 
addition, one set of tubes contained only 100 ul of labeled cAMP to 
determine total counts. This tube was counted without further 
processing. Another set of tubes contained labeled cAMP and 200 ul of 
buffer to serve as a blank. This was treated the same as the sample 
tubes. At the end of the incubation period each tube, except total 
counts, received 1 ml of ice-cold 50 mM sodium acetate buffer, was 
vortexed, and centrifuged in the cold for 15 min at 2000 g in a Sorvall 
RC-5 centrifuge. The tubes were decanted and blotted on absorbent paper. 
The tubes, containing the precipitated antibody complex, were counted 
for 1 min in a Searle Analytic gamma counter with a counting efficiency 
of 80%. 
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Calculation of Sample Cyclic AMP Content 
The amount of cAMP present in each 100 ul of sample was 
calculated using a program written in Applesoft basic and performed on 
an Apple II+ computer. The program employed the following method: 
1. The CPM for each set of duplicates was averaged. 
2. The average net CPM for all samples was calculated by 
subtracting the average counts of the blanks. 
3. The average net CPM of each standard or sample was expressed 
as a percent of the average net CPM of the "0" standard, 
which represents the counts bound to antibody in the absence 
of added cAMP. This value is the normalized percent bound, B, 
where B = CPM standard/CPM "O" standard, multiplied by 100 
and B = 100%. 0 
4. The logit of the percent bound for each standard is 
calculated (logit B = ln(B/(B0 -B))) and a regression of the 
logit on the log of the standard concentration is fit. This 
transformation fits the standard curve to a straight line and 
facilitates the evaluation of each unknown. 
5. The sample regression equation is calculated and the logit of 
percent bound for each sample is fit into the equation to 
determine the corresponding amount of cAMP present in the 
sample. 
6. The values obtained are then multiplied by the appropriate 
dilution factor and expressed as pmol cAMP/g tissue wet wt. 
The dilution factor for whole ventricles was 100, since one 
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ml out of 10 ml of the homogenate supernatant was lyophilized 
and 100 ul of 1 ml of the reconstituted sample was used in 
the assay. The dilution factor for ventricular slices was 20. 
One ml of two ml of the homogenate supernatant was 
lyophilized and then 100 ul of 1 ml of the reconstituted 
sample was used in the assay. In both cases the tissue water 
was considered negligible compared to the volume of acid in 
which the tissue was homogenized. 
7. The values obtained for the adenylate cyclase assays were 
multiplied by 8.5 since 100 ul of the final volume of 850 ul 
was used in the assay. The data was then expressed as pmol 
cyclic AMP/mg protein-min. 
H. Determination of Adenylate Cyclase Activity 
Membrane Preparation 
Rats were killed by decapitation with a guillotine (Stoetler 
Apparatus Company); the hearts were excised, placed in 0.9% saline at 
4°c, perfused retrogradely through the aorta with cold saline to remove 
blood in the coronary vasculature and cleaned of adipose tissue and 
clots. The ventricles were separated from the atria and frozen between 
brass clamps that were previously cooled in liquid nitrogen. The tissue 
was then immersed in liquid nitrogen to complete the freezing process. 
Tissue was stored at in liquid nitrogen until processed. 
Frozen tissue (approximately 150 mg) was weighed on a 
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Roller-Smith balance and placed in 2 ml of ice-cold grinding buffer (5 
mM Tris-HCl, 1mM MgC12 , 250 mM sucrose, ph 7.4). Preparations were 
exposed to two 15 s bursts of a Tekmar Tissumizer at setting 75. The 
homogenate was passed through four layers of surgical gauze and 
centrifuged at 48,000 g for 10 min in a Sorvall RC-5 refrigerated 
centrifuge. The pellet was resuspended in 20 volumes (v/original wet 
wt.) of ice-cold incubation buffer (75 mM Tris-HCl, 15 mM MgC12 , pH 7.4) 
with the Tissumizer at low speed. The pellets are was recentrifuged and 
resuspended twice. The final suspension contained approximately 2 mg of 
membrane protein per ml. 
Adenylate Cyclase Assay 
This procedure was based on the methods of O'Connor et al (8). 
Approximately 100 ug of membrane were added to a total volume of 150 ul 
of 75 mM Tris-HCl (pH 7.4), 8 mM KCl, 7.5 mM theophylline, 0.4 mM 
dithiothreitol, 0.4 mg/ml bovine serum albumin, 0.7 mM EGTA, 6 mM MgC12 , 
1mM ATP, 2.5 mM creatine phosphate, 0.075 mg/ml creatine phosphokinase, 
and 1.0 mM ascorbic acid in a 1.5 ml polyethylene microcentrifuge tube 
(Sarstedt) on ice. The tubes were incubated for 20 min at 30°C in a 
Dubnoff metabolic shaker. In certain assay conditions either 8 mM NaF, 
10-4 M Gpp(NH)p (guanylyl-imidodiphosphate), 10-4 M GTP (guanosine 
triphosphate), or 10-4 M GTP plus 10-9 to 10-3 M isoproterenol were 
included. After the incubation period the tubes were returned to the ice 
bath and the reaction was terminated by the addition of 700 ul of cold 
1.0 mM EDTA, 50 mM sodium acetate (pH 6.2). The assay tubes were 
centrifuged for 10 min at 10,000 g in a Eppendorf Microfuge Model 5414 
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and the supernatant was decanted into fresh tubes and stored at -40°C 
until assayed for cAMP. One hundred ul of supernatant were used directly 
in the assay as described above (see Section G). 
I. Beta-Adrenergic Receptor Characterization 
Membrane Preparation 
Suitable cardiac membrane preparations were prepared by a 
modification of the method of Baker et al (9). Ventricular tissue was 
acquired as explained in section H. 
Frozen ventricles (approximately 750 mg) were weighed on a 
Roller-Smith balance, minced with a sectioning blade, and placed in 10 
ml of ice-cold grinding buffer (5 mM Tris-HCl, 1 mM MgC12 , 250 mM 
sucrose, pH 7.4). The tissue was allowed to thaw then homogenized by 
means of 
(Brinkmann 
two 15 s bursts at setting 6 on a Polytron homogenizer 
Instruments). The homogenizer was rinsed with 5 
ST-10 
ml of 
grinding buffer and this was added to the homogenate. An equal volume of 
cold 1 M KCl (15 ml) was added to the homogenate and the mixture was 
continuously stirred on ice for 15 min. This procedure extracts 
contractile proteins and decreases non-specific binding of ligand. The 
homogenate was filtered through four layers of surgical gauze and 
centrifuged at 48,000 g for 15 min. The supernatant was discarded and 
the pellet resuspended in 25 volumes (v/w) of incubation buffer (75 mM 
Tris-HCl., 15 mM MgC12 , 1 mM ascorbic acid, pH 7.4) and recentrifuged and 
resuspended twice. The final suspension had a final protein 
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concentration of 0.6-1.0 mg/ml incubation buffer. 
Binding Assays 
This procedure was based on the methods of Lurie et al (10). The 
membrane preparation (250 ul) was added to 12x75 mm glass tubes on ice, 
containing (3H)-dihyroalprenolol (DHA, sp. act. 35.6 Ci/mmol, NEN) or 
DHA and (-)isoproterenol (10-3 M) in a final volume of 500 ul of 
incubation buffer. All assays were performed in duplicate. The tubes 
were vortexed briefly and incubated at 25°c for 30 min in a shaking 
water bath. When the incubation period was complete, binding was 
terminated by adding 4 ml of ice-cold buffer (75 mM Tris-HCl, 15 mM 
MgC12 , pH 7.4) to each tube and the samples were filtered (24 at a time) 
over GF/C glass-fiber filters (Whatman) using a cell harvester (Brandel 
Model M24). Each filter was washed 3 times with 3 ml of ice-cold buffer. 
The filters were placed in 5 ml mini-scintillation vials (Research 
Products International) and allowed to dry. Three and one half ml of 
scintillation fluid (3a70b, RPI) were added to each vial and the 
radioactivity was counted in a Packard Tri-Carb 460 liquid scintillation 
counter. Disintegrations per minute for each sample were calculated by 
the standard channels ratio method. This calculation was performed by a 
program operated by the counter. 
Specific binding (DHA bound to B-adrenergic receptors) was 
determined by subtracting DHA binding in the presence of 10-3 M 
(-)isoproterenol from DHA binding in the absence of isoproterenol. This 
concentration of isoproterenol was found to maximally inhibit DHA 
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binding in DHA-isoproterenol competition curves. Specific binding was 
generally 65-70% of total binding at the Kd for DHA. Specific binding 
was shown to be saturable and linearly related to protein concentration. 
Binding equilibrium was observed to occur within 10 min from initiation 
of the reaction. Total ligand bound was normally 1-3% Of the free 
ligand. 
Saturation Isotherms 
Heart membranes were incubated as indicated above in the 
presence of increasing concentrations of DHA (0.25-10 nM, approximately 
10,000-450,000 DPM) in the presence or absence of 1 mM isoproterenol. 
Specific binding was measured as indicated above after a 30 min 
incubation period. The results were analyzed according to the method of 
Scatchard (11). Beta-adrenergic receptor density and antagonist affinity 
were derived from this data. 
Competition Curves 
Heart membranes were incubated for 30 min as indicated above in 
the presence of a fixed concentration of DHA (2 nM) and increasing 
concentrations of (-)isoproterenol (10-9-10-3 M). Isoproterenol was used 
since it is considered not to have significant alpha-adrenergic receptor 
binding capacity. Under these conditions maximal binding represented 
1-3% of the total radioactivity added. Competition curves were analyzed 
by computer curve fitting techniques (13,14). A one or two class of 
binding sites model was accepted on the basis of the best fit as 
determined by the curve fit. Binding characteristics of the adrenergic 
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agonist, as opposed to antagonist, were derived via this analysis. 
Calculation of Beta-adrenergic Receptor Density and Antagonist Affinity 
The following abbreviations will be used in this discussion: 
L = concentration of free radioligand 
R = concentration of unoccupied binding sites 
RL = concentration of receptor bound with radioligand 
RT = total receptor concentration 
Kd = equlibrium dissociation constant 
In a saturation experiment the receptor concentration is held 
constant and RL is determined at equilibrium as a function of L. By the 
Law of Mass Action 
R + L = RL and 
Kd = (R*L)/RL *=multiplication 
Since the the total receptor concentration must be a sum of the free and 
bound concentrations 
RT = R + RL 
combining the last two equations and solving for RL gives 
RL = (RT*L)/(Kd+L) 
This equation describes a rectangular hyperbola and displays the 
saturability of the binding. In order to analyze this data it is much 
easier to represent it mathematically as a linear relationship, thus the 
Scatchard (11) or Rosenthal (12) transform is calculated. The parameters 
of this equation are usually represented by a different set of symbols: 
RL = B (Bound); L = F (Free); and RT = ~ax (maximal number of binding 
sites). By rearranging the last equation and inserting the new symbols 
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the equation becomes 
B/F = (-B/Kd) + (BmaxfKd) 
A plot of B/F on the ordinate versus B on the abscissa produces a 
straight line (when binding occurs at a single site) with a slope of 
-1/K d and a X-intercept of Buiax• Data that does not model to a one site 
fit is analyzed by the non-linear curve fitting program described below. 
In practice the data is prepared for this transformation in the 
follwing manner: 
1. Averages are calculated for each set of duplicates. 
2. Specific bound DPM are calculated by subtracting non-specific 
bound DPM (DPM in the presence of isoproterenol) from total 
bound (no isoproterenol) for each concentration of DHA. 
3. Specific bound DPM are converted to femtomoles of DHA/mg of 
membrane protein by multiplying by a conversion factor 
(fmol/DPM) and dividing by the membrane protein in each tube. 
Thus "B" is calculated. 
4. Subtracting specific bound DPM from the total DPM added to 
the tube gives free DPM. Free DPM is converted to 
concentration of free DHA by multiplying by the conversion 
factor and dividing by the volume of the assay (0.5 ml). 
Thereby "F" is calculated. 
5. B/F is calculated for each concentration of DHA. 
6. A regression of B/f on B is fit. The negative reciprocal of 
the slope of the line is Kd and the X-intercept is Bmax• 
Scatchard analysis is performed by using a Visi-Calc program on 
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the Apple II+ to obtain B and B/F values and Hewlett-Packard HP-11C 
calculator for fitting the regression line. 
Competition Curve Analysis 
This analysis was performed for the most part with the LIGAND 
program of Munson and Rodbard (13), as converted to Applesoft basic by 
Martin H. Teicher, Ph.D, on an Apple II+ computer. The program listing 
was acquired from the Biomedical Computing Technology Information 
Center, Vanderbilt Medical Center. 
LIGAND is a non-linear model fitting program which will analyze 
the results of ligand-binding studies using an exact physical chemical 
model with appropriate statistical methodology. No computational 
approximations or simplifications are used. Rather than transforming the 
data, the program calculates bound ligand concentration as a function of 
the total ligand concentrations for each ligand in the system. The 
mathematical model describes the reactions of n ligands, Li, binding to 
m classes of sites, R. 
J" 
Li + Rj = LiRj 
for 
i=1 to n, j=1 to m, 
each with an affinity constant: 
(A1) 
where Fi represents the free concentration of ligand i, Ej is the 
concentration of empty receptor j, and B .. is the concentration ligand i 1J 
bound to receptor j. Empty receptor, Ej, is defined by the conservation 
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of mass equation for receptors: 
for 
j=1 to m (A2) 
where R. is the total concentration of receptor j. Free ligand J 
concentration, Fi, is defined by the equation for conservation of 
ligand: 
for 
i=1 to n (A3) 
Here, Li is the total concentration of ligand i. Solving Eq. (A1) for 
Bij and substituting for Bij into Eqs. (A2) and (A3) yields 
for 
for 
Rj = Ej + KijEjFi 
j=1 to m 
L. = F. + 1 1 
i=1 to n 
Solving Eq. (A4) for E. yields 
J 
Ej = Rj/(1 + KijFi) 
for 
j=1 to m 
(A4) 
(A5) 
(A6) 
which may then be substituted into Eq. (A5) to give 
for 
i=1 to n (A7) 
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Equation (A7) is then solved numerically for Fi, given Li, Rj, and the 
matrix of values Kij• In turn, the solution for Fi may be substituted 
Eq. (A6) to find Ej, and then, using Eq. (A1), calculate Bij• Thus 
the bound concentration is calculated as a function of the total ligand 
into 
concentrations for the ligand, Bij(L1 ,L2 , ••• ,Ln) given the values of the 
binding parameters K .. and R .• 1J J 
Since this program calculates binding for any number of ligands 
at any number of binding sites it is especially suitable for determining 
the characteristics of agonist binding using competition assays. In 
practice, isoproterenol binding characteristics are determined as a 
function of the ability to compete with DHA binding. By knowing the 
binding characteristics of DHA without isoproterenol (see above) and the 
binding of DHA at every level of isoproterenol the program can then 
determine the binding characteristics of isoproterenol. Additionally the 
data can be modelled to different fits. That is, it can be determined 
whether isoproterenol is binding to one or more sites, the density of 
each site, and their affinities. As additional parameters (binding 
sites, etc.) are added to the model, the goodness of fit will tend to 
improve. The program will test whether the increase of goodness of fit 
for a model with additional parameters is significantly more than is 
expected on the basis of chance alone. The test is based on the "extra 
sum of squares" principle. An F ratio is calculated from the residual 
sums of squares (SS) of the deviations to the fitted curves and the 
degrees of freedom (df): 
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If the F value exceeds the tabulated value for the appropriate degrees 
of freedom and probability level the second fit is considered a 
significant improvement over the first. 
Competition curves were also analyzed by the ALLFIT program of 
DeLean, Munson and Rodbard (14) in the Applesoft version converted by 
Martin H. Teicher. This program analyzes groups of sigmoidal dose 
response curves. The model used is the four parameter logistic equation: 
Y = ((a-d)/(1 + (X/c)b)) + d 
where X and Y are the dose and the response respectively and a,b,c,d are 
the four fitted paramters: response at zero dose (a), slope factor (b), 
50% maximally efficient dose or EC50 (c) and response at "infinite" dose 
(d). This program was used independently to determine the aforementioned 
parameters for each competition curve, however comparison of curves 
sharing common parameters is also possible. 
J. Protein Determination 
This assay is based on the methods of Bradford (15) and is 
performed using the appropriate solution as supplied by Bio-Rad 
Laboratories. The assay is based on the observation that Coomassie 
Brilliant Blue G-250 exists in two color forms, red and blue. The red 
form is converted to the blue form upon binding of the dye to protein. 
The protein-dye complex was found to have a high extinction coefficient 
which affords great sensitivity in measurement of the protein. 
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One hundred microliters of standard (20-100 ug of bovine serum 
albumin) or sample were placed in 16x100 mm glass test tubes at room 
temperature. One hundred microliters of sample buffer (75 mM Tris-Hcl, 
15 mM MgC12, ph 7.4) were added to a separate test tube to serve as the 
blank (0 absorbance). To each tube was added 5.0 ml of Bradford dye 
reagent containing Coomassie Brilliant Blue G-250 0.01% (w/v), 4.7% 
(w/v) ethanol, and 8.5% (w/v) phosphoric acid. The mixtures were 
vortexed gently and binding allowed to reach equilibrium (5 min). The 
absorbance of each sample and standard was measured with a Beclanan DB-G 
grating spectrophotometer at 595 nm. The absorbance for the standards 
and samples were corrected for the blank. A standard curve was prepared 
by plotting absorbance versus concentration of the standards. Protein 
concentrations of the samples were determined from the standard curve. 
The standard curve was found to be linear between 20 and 100 ug and all 
samples were appropriately diluted to fall within this range. 
K. Plasma Glucose Analysis 
Blood was collected from the neck wound after decapitation in 
1.5 ml heparinized microcentifuge tubes. The samples were centrifuged 
for 3 min in an Eppendorf Model 5414 microfuge at 10,000 g. The plasma 
was transferred with Pasteur pipettes to clean 400 ul microfuge tubes 
and stored at -20°c until assayed. 
Plasma glucose concentrations were determined with a Yellow 
Springs Instruments Model 23A Glucose analyzer. The analyzer is 
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basically an oxidase enzyme hydrogen peroxide sensor as developed by Dr. 
Leland c. Clark and is capable of measuring glucose in plasma, serum, 
whole blood, and other biological and non-biological fluids. 
Glucose in the vicinity of the probe diffuses through the outer 
layer of the membrane, which is a polycarbonate material with pores 
large enough to pass glucose, oxygen, hydrogen peroxide, water and salt 
but small enough to exclude cells and enzymes. The glucose comes in 
contact with glucose oxidase which is immobilized in a resin between the 
inner and outer layer. The glucose is converted to gluconic acid and 
hydrogen peroxide by this enzyme. The hydrogen peroxide diffuses through 
the inner cellulose acetate layer, coming in contact with the platinum 
anode. The hydrogen peroxide is oxidized to liberate hydrogen ions, 
oxygen, and electrons. The oxygen is then reduced to water by a silver 
cathode. These two reactions yield a current proportional to the 
quantity of the hydrogen peroxide diffused, which is directly 
proportional 
of glucose 
measured and 
to the amount of glucose in the sample. The concentration 
in the sample is determined from the amount of glucose 
the volume of the sample, which is constant for all 
samples. The glucose analyzer was calibrated daily against known 
standards. Samples were analyzed in duplicate and the average of these 
is reported as mg/100 ml plasma. 
L. Statistical Analysis 
Statistical significance 
independent student's t test 
was determined by several methods. An 
was used to compare two groups. The 
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comparison of more than two groups was performed with an independent 
analysis of variance. The least significant difference technique was 
used for mean separation after significant F tests were completed. 
Analysis of covariance and linear regression were used to compare dose 
response curves. A p value of less than 0.05 was was considered as the 
minimum level to achieve significance. 
All analysis was performed with programs modified for the Apple 
II+ computer by either the author or David V. Defily. 
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